Umbhali: Gregory Harris
Umhla Wokudalwa: 10 Utshazimpuzi 2021
Hlaziya Umhla: 18 Eyenkanga 2024
Anonim
40K - THE SQUATS RETURN? THEY NEVER WENT AWAY - Warhammer 40,000 Lore/History
Ividiyo: 40K - THE SQUATS RETURN? THEY NEVER WENT AWAY - Warhammer 40,000 Lore/History

Umxholo

I-Lutein luhlobo lwevithamini olubizwa ngokuba yi-carotenoid. Inxulumene ne-beta-carotene kunye nevithamini A. Ukutya okunotye kwi-lutein kubandakanya izikhupha zamaqanda, i-broccoli, isipinatshi, i-kale, umbona, ipepile ye-orenji, iziqhamo ze-kiwi, iidiliya, ijusi yeorenji, zucchini, kunye ne squash. I-Lutein ifunxwa ngcono xa ithathwa ngesidlo esinamafutha aphezulu.

Abantu abaninzi bacinga nge-lutein njenge "vithamini yamehlo." Kuqhelekileyo kuthathwa ngomlomo ukunqanda izifo zamehlo ezinje ngesifo samehlo esikhokelela ekulahlekelweni kombono kubantu abadala (ukoyiswa kwe-macular degeneration okanye i-AMD), kunye neekati. Akukho bungqina bubonakalayo besayensi obuxhasa ukusetyenziswa kwe-lutein kwezinye iimeko.

Uninzi lweevithamini ezininzi zine-lutein. Bahlala bebonelela ngesixa esincinci, njenge-0.25 mg kwithebhulethi nganye.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe UMTHETHO zezi zilandelayo:


Inokwenzeka ukuba isebenze ...

  • Isifo samehlo esikhokelela kwilahleko yombono kubantu abadala (imeko enxulumene nobudala be-macular degeneration okanye i-AMD). Abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo babonakala benomngcipheko ophantsi wokuphuhlisa i-AMD. Kodwa abantu abasele besitya izixa eziphezulu ze-lutein banokungazuzi ngokwandisa ukutya kwabo ngakumbi. Ukuthatha izongezo ze-lutein ukuya kuthi ga kwiinyanga ezingama-36 kunokuphucula iimpawu ze-AMD. Ukuphucuka okukhulu kweempawu kunokubonwa xa i-lutein ithathwa ubuncinci unyaka kwiidosi ezingaphezulu kwe-10 mg, kwaye xa idityaniswa nezinye iivithamini ze-carotenoid. I-Lutein kubonakala ngathi ayigcini i-AMD ekubeni mandundu ekuhambeni kwexesha.
  • Iimpawu. Ukutya izixa eziphezulu ze-lutein kunxulunyaniswa nomngcipheko omncinci wokuphuhlisa i-cataract. Ukuthatha izongezo eziqukethe i-lutein kunye ne-zeaxanthin kunciphisa umngcipheko wokuphuhlisa i-cataract efuna ukususwa kotyando kubantu abatya imali encinci ye-lutein kunye ne-zeaxanthin njengenxalenye yokutya kwabo. Kwakhona, ukuthatha izongezo ze-lutein kubonakala kuphucula umbono kubantu abadala abasele bekrwada kwaye abasele bedla i-lutein eninzi kunye ne-zeaxanthin.

Kusenokwenzeka ukuba ayisebenzi ...

  • Isifo semiphunga esichaphazela iintsana (bronchopulmonary dysplasia). Uphando lubonisa ukuba ukunika abantwana i-lutein kunye ne-zeaxanthin ngomlomo akuwanciphisi amathuba okuphuhlisa i-bronchopulmonary dysplasia.
  • Isifo esibi emathunjini kwiintsana ezingaphambi kwexesha (i-necrotizing enterocolitis okanye i-NEC). Uphando lubonisa ukuba ukunika iintsana zangaphambi kwexesha i-lutein kunye ne-zeaxanthin ngomlomo akuthinteli i-necrotizing enterocolitis.
  • Imeko yamehlo ezuzwe njengelifa ebangela ukungaboni kakuhle ebusuku kunye nokulahleka kombono osecaleni (i-retinitis pigmentosa). Ukuthatha i-lutein ngomlomo akuphuculi umbono okanye ezinye iimpawu kubantu abane-retinitis pigmentosa.
  • Ukuphazamiseka kwamehlo kwiintsana ezingaphambi kwexesha ezinokubangela ubumfama (ukuphinda ubenokubona kwangaphambili). Uphando lubonisa ukuba ukunika iintsana zokuqala i-lutein kunye ne-zeaxanthin ngomlomo akuthinteli i-retinopathy ye-prematurity.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

  • Yehla kwimemori nakwizakhono zokucinga ezenzeka ngesiqhelo ngobudala. Abantu abadala abatya isixa esikhulu sokutya okuqukethe i-lutein kunye ne-zeaxanthin banokuba nenkumbulo engcono. Iziphumo ze-lutein kwizongezo kwimemori nakwizakhono zokucinga kubantu abadala azicacanga. Olunye uphando lubonisa ukuba ukuthatha i-lutein kunye ne-zeaxanthin njengezincedisi akuphuculi ukuthetha okanye imemori kubantu abadala. Kodwa ukuthatha i-lutein kunye okanye ngaphandle kwe-docosahexaenoic acid (DHA) kunokuphucula ukuthetha kunye nenkumbulo kubafazi abadala.
  • Isifo sikaLou Gehrig (amyotrophic lateral sclerosis okanye i-ALS). Uphando lwakwangoko lubonisa ukuba abantu abatya i-lutein engaphezulu njengenxalenye yokutya kwabo banomngcipheko ophantsi wokufumana i-ALS xa kuthelekiswa nabantu abatya izixa ezantsi ze-lutein.
  • Umhlaza webele. Uphando lubonisa ukuba amanqanaba aphezulu e-lutein egazini adityaniswa nomngcipheko omncinci wokuba nomhlaza wamabele.
  • Isifo sentliziyo. Olunye uphando lwabemi lubonisa ukuba abantu abatya izixa eziphezulu ze-lutein okanye bathathe izongezo ze-lutein banomngcipheko ophantsi weziganeko ezichaseneyo ezinxulumene nentliziyo njengokuhlaselwa kwentliziyo okanye ukubetha. Kodwa uphando lwezonyango lubonisa ukuba ukuthatha i-lutein nge-zeaxanthin ngomlomo akuthinteli ukufa ngenxa yesifo sentliziyo, ukubetha, isifo sentliziyo, okanye iintlungu zesifuba kubantu abadala.
  • Umhlaza womlomo wesibeleko. Uphando lwakwangoko lubonisa ukuba ukutya kancinci kwe-lutein njengenxalenye yokutya akunxulunyaniswa nomngcipheko okhulayo wokuba nomhlaza womlomo wesibeleko.
  • Imeko ezuzwe njengelifa ebangela ukulahleka kombono (choroideremia). Uphando lwakwangoko lubonisa ukuba ukuthatha i-20 mg ye-lutein yonke imihla iinyanga ezi-6 akuphuculi umbono kubantu abane-choroideremia.
  • Umhlaza wekolon, umhlaza we-rectal. Kukho iziphumo eziphikisanayo malunga nokuba ukutya okuqukethe ixabiso eliphezulu le-lutein kunokunciphisa umngcipheko we-colon okanye umdlavuza we-rectal.
  • Seswekile. Olunye uphando lubonisa ukuba amanqanaba asezantsi egazi e-lutein okanye ezinye i-carotenoids zinxulunyaniswa neengxaki zeswekile yegazi. Kwithiyori, ukuthatha i-lutein kunokunciphisa umngcipheko wokuba nesifo seswekile. Nangona kunjalo, olunye uphando lubonisa ukuba ukwanda kokutya kwe-lutein ekutyeni akuwunciphisi umngcipheko wokuba nesifo seswekile.
  • Umbono weengxaki kubantu abanesifo seswekile (isifo seswekile). Uphando lwakwangoko lubonisa ukuba ukuthatha i-lutein akuphuculi umbono kubantu abanesifo seswekile kunye nemeko yamehlo ebizwa ngokuba nesifo seswekile.
  • Umhlaza womqala. Uphando lwakwangoko lubonisa ukuba izixa eziphezulu ze-lutein ekutyeni zinxulunyaniswa nomngcipheko owehlileyo wokuba nomhlaza wesisu.
  • Ukuqhekeka. Abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo ababonakali benomngcipheko ophantsi wokuqhekeka.
  • Umhlaza wesisu. Abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo ababonakali benomngcipheko ophantsi wokuba nomhlaza wesisu.
  • Umhlaza wemiphunga. Obunye ubungqina bokuqala buchaza ukuba amanqanaba asezantsi egazi e-lutein adibene nomngcipheko okhulayo wokuba nomhlaza wemiphunga. Nangona kunjalo, olunye uphando lubonisa ukuba ukuthatha i-lutein akuchaphazeli umngcipheko wokukhula okanye ukubulawa ngumhlaza wemiphunga.
  • Umhlaza oqala kwiiseli ezimhlophe zegazi (engeyo-Hodgkin lymphoma). Uphando lwakwangoko lubonisa ukuba abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo okanye bathathe izongezo ze-lutein banokuba nethuba elisezantsi lokuphuhlisa i-non-Hodgkin lymphoma.
  • Umhlaza wepancreatic. Abantu abatya izixa eziphezulu ze-lutein ekudleni kwabo ababonakali benomngcipheko ophantsi wokuba nomhlaza wepancreatic.
  • Isifo seParkinson. Uphando lwakwangoko lubonisa ukuba izixa eziphezulu ze-lutein ekutyeni akunxulunyaniswa nomngcipheko owehlileyo wokuhlaselwa sisifo seParkinson.
  • Ingxaki yokukhulelwa ephawulwe luxinzelelo lwegazi kunye neprotein kumchamo (pre-eclampsia). Olunye uphando lubonisa ukuba amanqanaba aphezulu egazi e-lutein adibene nomngcipheko omncinci wokukhula koxinzelelo lwegazi xa ukhulelwe. Akucaci ukuba ukuthatha ii-lutein supplements kwehlisa umngcipheko woxinzelelo lwegazi xa ukhulelwe.
  • Umhlaza wedlala lobudoda. Uphando lwakwangoko lubonisa ukuba amanqanaba asezantsi egazi e-lutein awadibananga nomngcipheko okhulayo womhlaza webele.
  • Usulelo lweendlela zomoya. Uphando lwakwangoko lubonisa ukuba amanqanaba aphezulu egazi e-lutein awadibananga nokwehla komngcipheko wosulelo lomoya.
  • Ukuphuhliswa kwamehlo. Amanqanaba aphezulu egazi e-lutein kwabasetyhini abakhulelweyo adityaniswa kumbono ongcono ebantwaneni. Akucaci ukuba ukuthatha i-lutein supplements ngexesha lokukhulelwa kunenzuzo.
  • Uxinzelelo lwamehlo (asthenopia).
  • Ubuhlungu bemisipha obubangelwa kukuzilolonga.
  • Umbono wokuphulukana nokwakhiwa kolwelo phantsi kwenxalenye yamehlo ekuthiwa yirtina.
  • Ezinye iimeko.
Ubungqina obungakumbi buyafuneka ukukala ukusebenza kwe-lutein kwezi zinto zisetyenziswayo.

ILutein yenye yeecarotenoids ezimbini eziphambili ezifumaneka njengombala wombala kwiso lomntu (macula kunye neretina). Kucingelwa ukuba kusebenza njengesihluzi sokukhanya, ukukhusela izicubu zamehlo kumonakalo welanga.

Xa kuthathwa ngomlomo: ULutein unjalo NGOKUKHUSELEKILEYO xa kuthathwa ngomlomo. Ukutya ukuya kuthi ga kwi-20 mg ye-lutein mihla le njengenxalenye yokutya okanye njengesongezelelo kubonakala kukhuselekile.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: ULutein unjalo NGOKUKHUSELEKILEYO xa isetyenziswe kwiimali ezifumaneka kukutya.

Abantwana: ULutein unjalo NGOKUKHUSELEKILEYO xa ithathwa ngomlomo ngokwexabiso elifanelekileyo. Imveliso ethile (LUTEINofta, SOOFT Italia SpA) equkethe i-lutein 0.14 mg yonke imihla isetyenziswe ngokukhuselekileyo kwiintsana kwiiveki ezingama-36.

Ayaziwa ukuba le mveliso iyasebenzisana nawaphi na amayeza.

Ngaphambi kokuba uthathe le mveliso, thetha nengcali yezempilo ukuba ngaba uthatha nawaphi na amayeza.
I-Beta-carotene
Ukusebenzisa i-beta-carotene kunye ne-lutein kunokunciphisa inani le-lutein elinokufunxwa ngumzimba. I-lutein inokunciphisa okanye inyuse inani le-beta-carotene umzimba onokuyifunxa.
Vitamin E
Ukuthatha izongezo ze-lutein kunokunciphisa ubuninzi bevithamini E umzimba ubuthatha. Kwithiyori, ukuthatha i-lutein kunye ne-vitamin E kunye kunokunciphisa ukusebenza kwe-vitamin E.
IOlestra (indawo yamanqatha)
Sebenzisa indawo yamanqatha iOlestra kunciphisa ukugxila kwe-lutein yegazi kubantu abasempilweni.
La machiza alandelayo afundwe kuphando lwezesayensi:

NGOMLOMO:
  • Isifo samehlo esikhokelela kwilahleko yombono kubantu abadala (imeko enxulumene nobudala be-macular degeneration okanye i-AMD)Ukuthintela i-AMD, malunga ne-6-12 mg ye-lutein yonke imihla, nokuba kukutya okanye ukongezwa kuye kwasetyenziswa. Ukunciphisa iimpawu ze-AMD, kusetyenziswe i-10-20 mg yemihla ngemihla. Ukunciphisa iimpawu, kusetyenziswe i-10-12 mg ye-lutein yonke imihla.
  • NgamehloUkukhusela i-cataract, malunga ne-6-12 mg ye-lutein yonke imihla, nokuba kukutya okanye ukongezwa kuye kwasetyenziswa. Ukunciphisa iimpawu, kusetyenziswe i-15 mg ye-lutein kathathu ngeveki okanye i-10 mg ye-lutein kunye ne-2 mg ye-zeaxanthin mihla le.
Kukho i-44 mg ye-lutein ngekomityi nganye ye-kale ephekiweyo, i-26 mg ngekomityi yesipinatshi esiphekiweyo, kunye ne-3 mg ngekomityi nganye ye-broccoli.

Zonke-E-Lutein, Beta, epsilon-carotene-3,3’-diol, E-Lutein, Luteina, Lutéine, Lutéine Synthétique, Synthetic Lutein.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.


  1. IMachida N, Kosehira M, Kitaichi N.Iziphumo zeklinikhi yokongezwa kokutya kwe-lutein kunye nokufikeleleka okuphezulu kwe-bio kwi-macular pigment optical density kunye novakalelo lokuthelekisa: Uvavanyo lokuthelekisa lwe-placebo olulawulwa ngokungaboni ngamehlo. Izondlo. Ngo-2020; 12: 2966. Jonga i-abstract.
  2. UZuniga KE, uBhishophu NJ, uTurner AS. I-lutein yokutya kunye ne-zeaxanthin zinxulunyaniswa nememori yokusebenza kubantu abadala. IzeMpilo kaRhulumente kwiZempilo ngo-2020: 1-8. Jonga i-abstract.
  3. . UKobayashi J, uTominaga E, u-Ozeki M, u-Okubo T, uNakagawa K, uMiyazawa T. Uvavanyo olulawulwa ngokungaqhelekanga lokuqulunqwa kwamanzi kwe-lutein ebantwini. I-Biosci Biotechnol Biochem 2019; 83: 2372-4. Jonga i-abstract.
  4. Cota F, Costa S, Giannantonio C, Purcaro V, Catenazzi P, Vento G.Lutein ukongezwa kunye nokubuyiselwa kwengqondo kokungaphambi kwexesha: uhlalutyo lweemeta. J Umama okhulayo umntwana osandul 'ukuzalwa Med 2020: 1-6. Kwi-Intanethi ngaphambi kokuprinta. Jonga i-abstract.
  5. U-Lai JS, uVeetil VO, uLanca C, et al. I-lutein yoomama kunye ne-zeaxanthin yokugxila ngokunxulumene nembonakalo ye-acuity kwiminyaka emi-3 ubudala: Isifundo se-GUSTO. Izondlo 2020; 12: 274. Jonga i-abstract.
  6. UFeng L, uNie K, uJiang H, uFan W. Iziphumo zokuncedisa i-lutein ekwenziweni kweminyaka ehambelana nobudala. I-PLoS One 2019; 14: e022704848. Jonga i-abstract.
  7. I-Ren YB, i-Qi YX, i-Su XJ, i-Luan HQ, i-Sun Q.Ukunyanga okunyanzeliswa yi-lutein kwisongezo sesifo seswekile esinganyangekiyo: isifundo esibuyayo. Amayeza (iBaltimore) 2019; 98: e15404. Jonga i-abstract.
  8. UZhou Y, uWang T, uMeng Q, uZhai S. Umbutho wecarotenoids onomngcipheko wesifo somhlaza esiswini: uhlalutyo lweemeta. Iiklinikhi zeNutr 2016; 35: 109-16. Jonga i-abstract.
  9. U-Chen J, Jiang W, Shao L, Zhong D, Wu Y, Cai J. Umbutho phakathi kokutya i-antioxidants kunye nomngcipheko womhlaza wepancreatic: uhlalutyo lweemeta. I-Int J yokutya iSci Nutriti 2016; 67: 744-53. Jonga i-abstract.
  10. U-Chen F, u-Hu J, u-Liu P, u-Li J, u-Wei Z, u-Liu P.Ukutya kwe-Carotenoid kunye nomngcipheko we-non-Hodgkin lymphoma: uphononongo olucwangcisiweyo kunye neempendulo zedosi-meta-uhlalutyo lwezifundo zokujonga. UAnn Hematol 2017; 96: 957-65. Jonga i-abstract.
  11. Xu J, Ingoma C, Ingoma X, Zhang X, Li X. ICarotenoids kunye nomngcipheko wokophuka: uhlalutyo lweemeta zezifundo zokujonga. I-Oncotarget 2017; 8: 2391-9. Jonga i-abstract.
  12. Abaxhasi be-ET, iDarweesh SK, iBaena CP, et al. Iziphumo ze-lutein kwimpilo ye-cardiometabolic kuyo yonke ikhosi yobomi: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta. NdinguJ J Clin Nutrr 2016; 103: 481-94. Jonga i-abstract.
  13. I-Wolf-Schnurrbusch UE, i-Zinkernagel MS, i-Munk MR, i-Ebneter A, i-Wolf S.Ukuxhaswa kwe-Oral lutein kwandisa uxinano lwe-macular pigment kunye novakalelo lokuthelekisa kodwa hayi ngokudibanisa ne-polyunsaturated fatty acids. Utyalo mali lweOphthalmol Vis Sci 2015; 56: 8069-74. Jonga i-abstract.
  14. UMa L, uLiu R, uDu JH, et al. I-Lutein, zeaxanthin kunye ne-meso-zeaxanthin yokuncedisa ehambelana ne-macular pigment optical density. Izondlo 2016; 8. IPH: E426. Jonga i-abstract.
  15. UShininojima A, uSawa M, uSekiryu T, et al. Isifundo esilawulwa ngokungahleliwe sokulawulwa kwe-antioxidant kunye ne-lutein ye-chorioretinopathy engapheliyo. I-Ophthalmologica 2017; 237: 159-66. Jonga i-abstract.
  16. Zhang PC, Wu CR, Wang ZL, Wang LY, Han Y, Sun SL, et al. Iziphumo zokuncedisa i-lutein ekusebenzeni ngokubonakalayo kwi-nonproliferative diabetic retinopathy. I-Asia Pac J yeKlinikhi yeNutriti 2017; 26: 406-11. Jonga i-abstract.
  17. U-Evans JR, uLawrenson JG. I-vitamin e-antioxidant kunye ne-mineral supplements yokunciphisa ukuqhubela phambili kwe-macular degeneration. Isiseko sedatha yeCochrane Isityhi 2017; 7: CD000254. Jonga i-abstract.
  18. Ukuhlafuna i-EY, iSanGiovanni JP, uFerris FL, et al. I-Lutein / zeaxanthin yonyango lwe-cataract enxulumene nobudala: I-AREDS2 ingxelo yolingo olungenamkhethe. 4. IJAMA Ophthalmol. NgoJulayi 2013; 131: 843-50. Jonga i-abstract.
  19. Ukuhlafuna i-EY, iiClemons TE, iAgrón E, et al. Iziphumo ze-Omega-3 Fatty Acids, Lutein / Zeaxanthin, okanye enye into yokuNcedisa ngokuNika amandla kwiCognitive Function: I-AREDS2 Randomised Trial Trial. JAMA. Ngo-2015 uAgasti 25; 314: 791-801. Jonga i-abstract.
  20. Iibhondi ze-DE, iHarrington M, i-Worrall BB, et al. Iziphumo zetyathanga elide? -3 fatty acids kunye ne-lutein + zeaxanthin isongezelelo kwiziphumo zentliziyo: iziphumo zesifundo se-Eye-Related Eye Disease Study 2 (AREDS2). JAMA Ngaphakathi Med. Ngo-2014 ngoMeyi; 174: 763-71. Jonga i-abstract.
  21. UWang X, Jiang C, uZhang Y, et al. Indima yokongezwa kwe-lutein kulawulo lokuchaphazeleka okunxulumene nobudala be-macular: Uhlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. Ophthalmic Res. Ngo-2014; 52: 198-205. Jonga i-abstract.
  22. UTakeda A, uNyssen OP, uSyed A, et al. I-Vitamin A kunye ne-carotenoids kunye nomngcipheko wesifo sika-Parkinson: ukuphononongwa ngokuchanekileyo kunye nokuhlaziywa kwemeta. Neuroepidemiology. Ngo-2014; 42: 25-38. Jonga i-abstract.
  23. UManzoni P, uGalione R, uBonetti P, et al. I-Lutein kunye ne-zeaxanthin yokuncedisa kwi-preterm ye-low-birth-weight weight neonates in neonatal intensive care units: a multicenter randomized trial trial.NdinguJ Perinatol. Ngo-2013 uJan; 30: 25-32. Jonga i-abstract.
  24. Ma L, Hao ZX, Liu RR, et al. Uhlalutyo lwe-meta-impendulo yohlalutyo lwe-lutein kunye ne-zeaxanthin yokutya ngokunxulumene nomngcipheko we-cataract enxulumene nobudala. Amangcwaba eArch Clin kwi-Ophthalmol. Ngo-2014 uJan; 252: 63-70. Jonga i-abstract.
  25. U-Liu XH, uYu RB, uLiu R, et al. Umanyano phakathi kwe-lutein kunye ne-zeaxanthin kunye nomngcipheko we-cataract: Uhlalutyo lwe-meta. Izondlo. Ngo-2014 uJan 22; 6: 452-65. Jonga i-abstract.
  26. U-Liu R, uWang T, uZhang B, et al. I-Lutein kunye ne-zeaxanthin yokuncedisa kunye nokunxulumana nomsebenzi obonakalayo kwinto enxulumene nobudala be-macular degeneration. Tyala imali kwi-Ophthalmol Vis Sci. Ngo-2014 uDisemba 16; 56: 252-8. Uphononongo. Jonga i-abstract.
  27. I-XX, i-Xing YAM, i-Yu LF, et al. Ukutya kweCarotenoid kunye nomngcipheko wesifo somhlaza: uhlalutyo lweemeta. I-Asia Pac J Umhlaza ngaphambili. Ngo-2013; 14: 1911-8. Jonga i-abstract.
  28. UCui YH, uJing CX, uPan HW. Umbutho wee-antioxidants zegazi kunye neevithamini ezinomngcipheko we-cataract enxulumene nobudala: uhlalutyo lweemeta kwizifundo zokujonga. NdinguJ oNyango lweeKlinikhi. Ngo-2013; 98: 778-86. Jonga i-abstract.
  29. UGarcía-Layana A, uRecalde S, uAlamán AS, uRobredo PF. Iziphumo ze-lutein kunye ne-docosahexaenoic Acid supplementation kwi-macular pigment optical density kwisilingo esilawulwa ngokungahleliwe. Izondlo. Ngo-2013 uFebruwari 15; 5: 543-51. Jonga i-abstract.
  30. UFitzgerald KC, O'Reilly ÉJ, uFondell E, okqhubekayo. Ukungeniswa kwe-vitamin C kunye ne-carotenoids kunye nomngcipheko we-amyotrophic lateral sclerosis: iziphumo ezidibeneyo ezivela kwizifundo ezi-5 zeqela. U-Ann Neurol. Ngo-2013; 73: 236-45. Jonga i-abstract.
  31. Liew SH, Gilbert CE Spector TD Mellerio J Van Kuijk FJ Beatty S Fitzke F Marshall J Hammond CJ. Ubungakanani be-retinal ubukhulu obuhambelana kakuhle ne-macular pigment optical density. Ukuboniswa kwamehlo. Ngo-2006; 82: 915-920.
  32. ULyle, B. J., Mares-Perlman, J. A., Klein, B. E., Klein, R., Palta, M., Bowen, P. E., noGreger, J. L. Serum carotenoids kunye neetopherol kunye neziganeko zekati yenyukliya enxulumene nobudala. NdinguJ J Clin Nutr 1999; 69: 272-277. Jonga i-abstract.
  33. UGoodman, MT, Kiviat, N., McDuffie, K., Hankin, JH, Hernandez, B., Wilkens, LR, Franke, A., Kuypers, J., Kolonel, LN, Nakamura, J., Ing, G. , Isebe, B., Bertram, CC, Kamemoto, L., Sharma, S., kunye noKilleen, J. Umanyano lwee-micronutrients zeplasma ezinobungozi be-dysplasia yomlomo wesibeleko eHawaii. Umhlaza we-Epidemiol. Ngo-1998; 7: 537-544. Jonga i-abstract.
  34. UThurnham, D. I., Northrop-Clewes, C. A., Paracha, P. I., kunye noMcLoone, U. J. Ukubaluleka okunokwenzeka kotshintsho olufanayo kwi-plasma lutein nakwi-retinol kwiintsana zasePakistan ngexesha lehlobo. UBr. J. Nutrr. Ngo-1997; 78: 775-784. Jonga i-abstract.
  35. Pool-Zobel, B. L., Bub, A., Muller, H., Wollowski, I., and Rechkemmer, G. Ukusetyenziswa kwemifuno kunciphisa ukonzakala kwemfuza ebantwini: iziphumo zokuqala zolingo longenelelo lomntu ngokutya okune-carotenoid. ICarcinogenesis 1997; 18: 1847-1850. Jonga i-abstract.
  36. Iliwa, C. L., Flatt, S. W., Wright, F. A., Faerber, S., Newman, V., Kealey, S., kunye noPierce, J. P. Ukuphendula kwe-carotenoids kukungenelela okuphezulu kokutya kwemifuno eyilelwe ukuthintela ukuphindaphinda komhlaza wamabele. Umhlaza we-Epidemiol. Ngo-1997; 6: 617-623. Jonga i-abstract.
  37. Iribarren, C., Folsom, A. R., Jacobs, D. R., Jr., Gross, M. D., Belcher, J. D., kunye no-Eckfeldt, J. H. Umbutho wamanqanaba e-vithamini ye-serum, i-LDL ifaneleke kwi-oxidation, kunye ne-autoantibodies ngokuchasene ne-MDA-LDL ene-carotid atherosclerosis. Isifundo solawulo lwamatyala. Abaphandi be-ARIC. Umngcipheko we-Atherosclerosis kuluntu. IArterioscler iTromb. IVasc. IBiol 1997; 17: 1171-1177. Jonga i-abstract.
  38. IBates, C. J., Chen, S. J., Macdonald, A., kunye noHolden, R. Ubungakanani bevithamini E kunye ne-carotenoid pigment kwii-lens zomntu ezigwenxa, kunye nefuthe lesongezelelo sokutya. I-Int J Vitam. INutr Res. Ngo-1996; 66: 316-321. Jonga i-abstract.
  39. UGartner, C., Stahl, W., kunye no-Sies, H. Ukonyuka okukhethiweyo kwinqanaba le-chylomicron ye-xanthophylls lutein kunye ne-zeaxanthin xa kuthelekiswa ne-beta-carotene emntwini. Int.J.Vitam, iNutr.Res. Ngo-1996; 66: 119-125. Jonga i-abstract.
  40. Yeum, K. J., Booth, S. L., Sadowski, J. A., Liu, C., Tang, G., Krinsky, N. I., kunye noRussell, R. M. Impendulo yeplasma yabantu xa kungeniswa ukutya okulawulwayo okuphezulu kwiziqhamo kunye nemifuno. NdinguJ. Kliniki uNutr 1996; 64: 594-602. Jonga i-abstract.
  41. UMartin, K. R., Failla, M. L., noSmith, J. C., Jr.Beta-carotene kunye ne-lutein bakhusela i-HepG2 iiseli zesibindi zomntu ngokuchasene nomonakalo obangelwe yi-oxidant. UJutut. Ngo-1996; 126: 2098-2106. Jonga i-abstract.
  42. I-Hammond, i-BR, i-Jr, i-Curran-Celentano, i-J, i-Judd, i-S, i-Fuld, i-K., i-Krinsky, i-NI, i-Wooten, i-BR kunye ne-Snodderly, i-DM Ukwahlukana ngokwesondo kwi-macular pigment Iipateni zokutya. Umbono Res. Ngo-1996; 36: 2001-2012. Jonga i-abstract.
  43. IHammond, B. R., Jr., iFuld, K., kunye neCurran-Celentano, J. Macular pigment density kumawele e-monozygotic. Tyala imali kwi-Ophthalmol. Ngo-1995; 36: 2531-2541. Jonga i-abstract.
  44. UNussbaum, J. J., Pruett, R. C., noDelori, F. C. Iimbono zembali. Umbala omthubi we-macular. Iminyaka engama-200 yokuqala. URetina 1981; 1: 296-310. Jonga i-abstract.
  45. Ukuhlafuna i-EY, iiClemons TE, iSanGiovanni JP, et al. Isifo seLiso esiNxulumene neMinyaka yoBudala 2 kwiQela loPhando. I-Lutein + zeaxanthin kunye ne-omega-3 fatty acids ye-macular degeneration ehambelana nobudala: Isifundo se-Eye-Related Eye Disease Study 2 (AREDS2). IJAMA 2013; 309: 2005-2015. Jonga i-abstract.
  46. UMurray, IJ, Makridaki, M., van der Veen, RL, Carden, D., Parry, NR, kunye neBerendschot, ukuxhaswa kweTT Lutein kwisithuba sonyaka omnye kwi-AMD yokuqala kunokuba nefuthe elincinci kubuhle bokubonwayo: i Cacile isifundo. Tyala imali kwi-Ophthalmol. Ngo-2013; 54: 1781-1788. Jonga i-abstract.
  47. IHammond, B. R., Jr., Fletcher, L.M, kunye no-Elliott, J. G. Glare ukukhubazeka, ukubuyiswa kwefotostress, kunye nokwahluka kwe-chromatic: ubudlelwane ne-macular pigment kunye ne-serum lutein kunye ne-zeaxanthin. Tyala imali kwi-Ophthalmol. Ngo-2013; 54: 476-481. Jonga i-abstract.
  48. Loughman, J., Nolan, J. M., Howard, A. N., Connolly, E., Meagher, K., kunye noBeatty, S. Impembelelo yokwandiswa kombala we-macular ekusebenzeni ngokubonakalayo kusetyenziswa iindlela ezahlukeneyo zecarotenoid. Tyala imali kwi-Ophthalmol. Ngo-2012; 53: 7871-7880. Jonga i-abstract.
  49. IHammond, B. R., Jr. kunye noFletcher, L. M. Impembelelo ye-carotenoids lutein kunye ne-zeaxanthin ekusebenzeni ngokubonakalayo: isicelo kwi-baseball. NdinguJ. Clin. Ngo-2012; 96: 1207S-1213S. Jonga i-abstract.
  50. I-SanGiovanni, J. P. kunye neNeuringer, M. Indima yokubeka ye-lutein kunye ne-zeaxanthin njengeearhente zokukhusela ngokuchasene nokubola okuhambelana nobudala: isithembiso semfuza yemolekyuli yokukhokela ubuchwephesha kunye nophando lokuguqula ebaleni. NdinguJ. Clin. Ngo-2012; 96: 1223S-1233S. Jonga i-abstract.
  51. UJohnson, E. J. Indima enokubakho ye-lutein kunye ne-zeaxanthin ekusebenzeni kwengqondo kubantu abadala. NdinguJ. Clin. Ngo-2012; 96: 1161S-1165S. Jonga i-abstract.
  52. UKaya, S., Weigert, G., Pemp, B., Sacu, S., Werkmeister, RM, Dragostinoff, N., Garhofer, G., Schmidt-Erfurth, U., kunye noSchmetterer, L.Ukuthelekiswa kombala we-macular. kwizigulana ezinento yokwenza nobudala be-macular degeneration kunye nezifundo zolawulo olusempilweni- isifundo esisebenzisa ukubonakaliswa kwe-fundral fundus. U-Acta Ophthalmol. Ngo-2012; 90: e399-e403. Jonga i-abstract.
  53. Schweiggert, R. M., Mezger, D., Schimpf, F., Steingass, C. B., noCarle, R. Impembelelo ye-chromoplast morphology kwi-carotenoid bioaccessibility ye-carrot, imango, ipapaya, kunye netumato. Ukutya Chem 12-15-2012; 135: 2736-2742. Jonga i-abstract.
  54. IRos, MM, Bueno-de-Mesquita, HB, Kampman, E., Aben, KK, Buchner, FL, Jansen, EH, van Gils, CH, Egevad, L., Overvad, K., Tjonneland, A., Roswall , N., Boutron-Ruault, MC, Kvaskoff, M., Perquier, F., Kaaks, R., Chang-Claude, J., Weikert, S., Boeing, H., Trichopoulou, A., Lagiou, P, uP. ., Dilis, V., Palli, D., Pala, V., Sacerdote, C., Tumino, R., Panico, S., Peeters, PH, Gram, IT, Skeie, G., Huerta, JM, Barricarte. , A., Quiros, JR, Sanchez, MJ, Buckland, G., Larranaga, N., Ehrnstrom, R., Wallstrom, P., Ljungberg, B., Hallmans, G., Isitshixo, TJ, Allen, NE, Khaw, KT, Wareham, N., Brennan, P., Riboli, E., kunye noKiemeney, LA Plasma carotenoids kunye noxinzelelo lwe-vitamin C kunye nomngcipheko we-urothelial cell carcinoma kwi-European Prospential Investigation kwiCancer and Nutrition. NdinguJ J Clin Nutriti 2012; 96: 902-910. Jonga i-abstract.
  55. UBernstein, PS, Ahmed, F., Liu, A., Allman, S., Sheng, X., Sharifzadeh, M., Ermakov, I., noGellermann, W. Ukucatshulwa kombala we-Macular kubathathi-nxaxheba be-AREDS2: isifundo esincedisayo Izifundo ze-AREDS2 zibhalise kwiziko lemehlo laseMoran. Tyala imali kwi-Ophthalmol. Ngo-2012; 53: 6178-6186. Jonga i-abstract.
  56. Ma, L., Yan, SF, Huang, YM, Lu, XR, Qian, F., Pang, HL, Xu, XR, Zou, ZY, Dong, PC, Xiao, X., Wang, X., Ilanga, I-TT, iDou, i-HL, kunye ne-Lin, i-XM Iziphumo ze-lutein kunye ne-zeaxanthin kwi-macular pigment kunye nomsebenzi obonakalayo kwizigulana ezinesifo esasineminyaka yobudala esihambelana nokubola. I-ophthalmology 2012; 119: 2290-2297. Jonga i-abstract.
  57. Chew, EY, Clemons, T., SanGiovanni, JP, Danis, R., Domalpally, A., McBee, W., Sperduto, R., kunye noFerris, FL Isifundo esiNxulumene neMinyaka yoNyango lweZifo zeLiso 2 (AREDS2): isifundo Uyilo kunye neempawu ezisisiseko (ingxelo ye-AREDS2 inombolo 1). I-ophthalmology 2012; 119: 2282-2289. Jonga i-abstract.
  58. Ma, L., Dou, HL, Huang, YM, Lu, XR, Xu, XR, Qian, F., Zou, ZY, Pang, HL, Dong, PC, Xiao, X., Wang, X., Ilanga, I-TT, kunye neLin, i-XM Ukuphuculwa komsebenzi we-retinal kwimo yobudala enxulumene nobudala emva kokuwohloka kwe-lutein kunye ne-zeaxanthin: ityala elilawulwa ngokungenamsebenzi, elifihliweyo, elilawulwa yi-placebo. Ndingu. J. Opthalmol. Ngo-2012; 154: 625-634. Jonga i-abstract.
  59. UGiordano, P., Scicchitano, P., Locorotondo, M., Mandurino, C., Ricci, G., Carbonara, S., Gesualdo, M., Zito, A., Dachille, A., uCaputo, P., kunye noC. URiccardi, R., Frasso, G., uLassandro, G., Di, Mauro A., kunye neCiccone, MM Carotenoids kunye nomngcipheko wentliziyo. I-Curr. IPhepha. 2012; 18: 5577-5589. Jonga i-abstract.
  60. UGoltz, S. R., Campbell, W. W., Chitchumroonchokchai, C., Failla, M. L., kunye noFerruzzi, M. G. Meal triacylglycerol iprofayile yokumodareyitha ukufakwa emva kwe-carpenoids ebantwini. I-Mol. YeNutr yokutya yokutya. Ngo-2012; 56: 866-877. Jonga i-abstract.
  61. URiccioni, G., Speranza, L., Pesce, M., Cusenza, S., D'Orazio, N., kunye noGlade, M. J. Inoveli ye-phytonutrient enegalelo kukhuselo lwe-antioxidant kwisifo sentliziyo. Isondlo 2012; 28: 605-610. Jonga i-abstract.
  62. Dreher, M.L Pistachio nuts: ukwakheka kunye nezibonelelo ezinokubakho kwezempilo. Isondlo. Ngo-2012; 70: 234-240. Jonga i-abstract.
  63. UTanaka, T., Shnimizu, M., kunye no-Moriwaki, H. Cancer icoprevention yi-carotenoids. Iimolekyuli. Ngo-2012; 17: 3202-3242. Jonga i-abstract.
  64. IVallverdu-Queralt, A., Martinez-Huelamo, M., Arranz-Martinez, S., Miralles, E., kunye neLamuela-Raventos, RM Umahluko kumxholo wecarotenoid weetchups kunye nee-gazpachos nge-HPLC / ESI (Li (+) -MS / MS edityaniswe namandla abo e-antioxidant. J Sci Ukutya kwezolimo. 8-15-2012; 92: 2043-2049. Jonga i-abstract.
  65. UFerguson, uL. R. noSchlothauer, R. C. Indima enokubakho yezixhobo ze-genomics ezinesondlo ekuqinisekiseni ukutya okuphezulu kwezempilo kulawulo lomhlaza: i-broccoli njengomzekelo. I-Mol. YeNutr yokutya yokutya. Ngo-2012; 56: 126-146. Jonga i-abstract.
  66. Sabour-Pickett, S., Nolan, J. M., Loughman, J., kunye noBeatty, S. Ukuphononongwa kobungqina bentsholongwane kwindima yokhuselo lwe-macular carotenoids yokuwohloka okuhambelana nobudala be-macular. I-Mol. YeNutr yokutya yokutya. Ngo-2012; 56: 270-286. Jonga i-abstract.
  67. IHoltan, SG, O'Connor, HM, Fredericksen, ZS, Liebow, M., Thompson, CA, Macon, WR, Micallef, IN, Wang, AH, Slager, SL, Habermann, TM, Call, TG, kunye neCerhan, I-JR yokutya-rhoqo kwimibuzo esekwe kwimibuzo eqikelela amandla e-antioxidant kunye nomngcipheko we-non-Hodgkin lymphoma. Int. J. Umhlaza 9-1-2012; 131: 1158-1168. Jonga i-abstract.
  68. Ucebile, u-SP, uStiles, uW, uGraham-Hoffman, K., uLevin, uM., URuskin, uD., U-Wrobel, uJ., UPaki, u-DW, noThomas, uC. ye-zeaxanthin kunye nomsebenzi obonakalayo kwizigulana ezinesifo se-atrophic ezinxulumene nobudala be-macular degeneration: iZeaxanthin kunye neVisual Function Study (ZVF) FDA IND # 78, 973. Optometry. Ngo-2011; 82: 667-680. Jonga i-abstract.
  69. UPiermarocchi, S., Saviano, S., Parisi, V., Tedeschi, M., Panozzo, G., Scarpa, G., Boschi, G., noLo, uGiudice G.Carotenoids kwisifundo esinxulumene nobudala seMaculopathy Italian Study ( I-CARMIS): iziphumo zeminyaka emibini yesifundo esingahleliwe. I-Eur. J. Epthalmol. Ngo-2012; 22: 216-225. Jonga i-abstract.
  70. UDani, C., Lori, I., Favelli, F., Frosini, S., Messner, H., Wanker, P., De, Marini S., Oretti, C., Boldrini, A., Massimiliano, uC. , IBragetti, P., kunye neGermini, C. I-Lutein kunye ne-zeaxanthin yokuncedisa kwiintsana zangaphambi kokukhusela ukuthintela ukuphinda kubenakho ukubakho ngaphambi kwexesha: isifundo esilawulwa ngokungahleliwe. J. Matern, Ubuthathaka beMetal ye-Neonatal Med. Ngo-2012; 25: 523-527. Jonga i-abstract.
  71. UConnolly, E. E., Beatty, S., Loughman, J., Howard, A. N., Louw, M. S., noNolan, J. M.Ukuxhaswa nazo zontathu ii-macular carotenoids: impendulo, uzinzo, kunye nokhuseleko. Tyala imali kwi-Ophthalmol. Ngo-2011; 52: 9207-9217. Jonga i-abstract.
  72. Romagnoli, C., Giannantonio, C., Cota, F., Papacci, P., Vento, G., Valente, E., Purcaro, V., noCosta, S. Isifundo esinokwenzeka, esingenamkhethe, esingaboniyo ngokuthelekisa i-lutein kwi-placebo yokunciphisa ukwenzeka kunye nobukrakra be-retinopathy yobudala bokuqala. J. Matern, Ubuthathaka beMetal ye-Neonatal Med. 2011; 24 iSuppl 1: 147-150. Jonga i-abstract.
  73. I-Thyagarajan, B., Meyer, A., Smith, LJ, Beckett, WS, Williams, OD, Gross, MD, kunye noJacobs, DR, Jr.Ukugxininiswa kwe-carumenoid yeserum kuqikelela ukusebenza kwemiphunga kubantu abadala abancinci: iCoronary Artery Risk Development in Abantu abadala abancinci (CARDIA). NdinguJ. Clin. Ngo-2011; 94: 1211-1218. Jonga i-abstract.
  74. Ma, L., Dou, HL, Wu, YQ, Huang, YM, Huang, YB, Xu, XR, Zou, ZY, kunye neLin, i-XM Lutein kunye nokutya kwe-zeaxanthin kunye nomngcipheko wokuwohloka okuhambelana nobudala be-macular: uphononongo lwenkqubo kunye nohlalutyo lweemeta. UBr. J. Nutrr. Ngo-2012; 107: 350-359. Jonga i-abstract.
  75. I-Weigert, G., Kaya, S., Pemp, B., Sacu, S., Lasta, M., Werkmeister, RM, Dragostinoff, N., Simader, C., Garhofer, G., Schmidt-Erfurth, U. kunye no-A. , kunye noSchmetterer, L.Iziphumo zokuncedisa i-lutein kwi-macular pigment optical density kunye ne-visual acuity kwizigulana ezinokonakala okuhambelana nobudala be-macular. Tyala imali kwi-Ophthalmol. Ngo-2011; 52: 8174-8178. Jonga i-abstract.
  76. I-Sasamoto, Y., Gomi, F., Sawa, M., Tsujikawa, M., kunye noNishida, K. Iziphumo zokuncedisa i-lutein yonyaka we-1 kulungelelwaniso lwe-macular pigment optical function and visual function. Ingcwaba leArch.Clin. Exp. IOphthalmol. Ngo-2011; 249: 1847-1854. Jonga i-abstract.
  77. URubin, LP, Chan, GM, Barrett-Reis, BM, Fulton, AB, Hansen, RM, Ashmeade, TL, Oliver, JS, Mackey, AD, Dimmit, RA, Hartmann, EE, kunye no-Adamkin, isiphumo se-DH sonyango lwe-carotenoid kwiiplasma carotenoids, ukudumba kunye nokukhula okubonakalayo kwiintsana ezizelwe ngaphambi kwexesha. J Perinatol. Ngo-2012; 32: 418-424. Jonga i-abstract.
  78. URavindran, RD, Vashist, P., Gupta, SK, Oselula, IS, Maraini, G., Camparini, M., Jayanthi, R., John, N., Fitzpatrick, KE, Chakravarthy, U., Ravilla, TD, kunye noFletcher, umbutho we-AE oguqukayo we-vitamin C kunye ne-cataract kubantu abadala e-India. Ophthalmology 2011; 118: 1958-1965. Jonga i-abstract.
  79. I-Saxena, S., Srivastava, P., kunye neKhanna, V. K. Antioxidant supplementation iphucula i-platelet membrane fluidity kwi-idiopathic retinal periphlebitis (isifo se-Eales). J. Ocul, iParmacol kunye noTher. Ngo-2010; 26: 623-626. Jonga i-abstract.
  80. UZeimer, M.B, Kromer, I., Spital, G., Lommatzsch, A., noPauleikhoff, D. I-telangiectasia ye-Macular: iipateni zokuhanjiswa kwe-macular pigment kunye nokuphendula kwisongezelelo. Iretina 2010; 30: 1282-1293. Jonga i-abstract.
  81. Bartlett, H., Howells, O., kunye no-Eperjesi, F. Indima yovavanyo lwe-macular pigment kwinkqubo yeklinikhi: uphononongo. Iklinikhi. Ngo-2010; 93: 300-308. Jonga i-abstract.
  82. ICapeding, R., Gepanayao, C. P., Calimon, N., Lebumfacil, J., Davis, A. M., Stouffer, N., kunye noHarris, B. J. Isondlo. J. Ngo-2010; 9: 22. Jonga i-abstract.
  83. UBerson, EL, Rosner, B., Sandberg, MA, Weigel-DiFranco, C., Brockhurst, RJ, Hayes, KC, Johnson, EJ, Anderson, EJ, Johnson, CA, Gaudio, AR, Willett, WC, kunye noSchaefer Uvavanyo lweklinikhi lwe-lutein kwizigulana ezine-retinitis pigmentosa efumana ivithamini A. Arch.Ophthalmol. Ngo-2010; 128: 403-411. Jonga i-abstract.
  84. Takeda, S., Masuda, Y., Usuda, M., Marushima, R., Ueji, T., Hasegawa, M., kunye noMaruyama, C. Iziphumo ze-mayonnaise kwi-postprandial serum lutein / zeaxanthin kunye ne-beta-carotene abantu. UJutut Sci. Vitaminol. (Tokyo) 2009; 55: 479-485. Jonga i-abstract.
  85. Teixeira, VH, Valente, H. F., Casal, S. I., Marques, A. F., and Moreira, P. A. I-Antioxidants ayikuthinteli ukwenza umthambo emva kokuzilolonga kwaye inokulibazisa ukubuyiswa kwemisipha. IMidlalo yeSci Exerc. Ngo-2009; 41: 1752-1760. Jonga i-abstract.
  86. IPerrone, S., Longini, M., Marzocchi, B., Picardi, A., Bellieni, CV, Proietti, F., Rodriguez, A., Turrisi, G., kunye neBuonocore, G. Iziphumo ze-lutein kuxinzelelo lwe-oxidative. kwikota elisanda kuzalwa: isifundo somqhubi. Neonatology. Ngo-2010; 97: 36-40. Jonga i-abstract.
  87. Ma, L., Lin, X. M., Zou, Z. Y., Xu, X. R., Li, Y., kunye no-Xu, R. Unyango lwe-lutein lweeveki ezili-12 luphucula umsebenzi wokubonwayo kubantu baseTshayina abanesibonakaliso sokukhanya esikude kwikhompyuter. UBr. J. Nutrr. Ngo-2009; 102: 186-190. Jonga i-abstract.
  88. Yagi, A., Fujimoto, K., Michihiro, K., Goh, B., Tsi, D., noNagai, H. Iziphumo zokuncedisa i-lutein kukhathala olubonakalayo: Uhlalutyo lwe-psychophysiological. Iapile. Ngo-2009; 40: 1047-1054. Jonga i-abstract.
  89. I-Vojnikovic, B., Kovacevic, D., Njiric, S., kunye neCoklo, M. Iziphumo zexesha elide ezinxulumene nonyango lokudodobala okuhambelana nobudala kunye ne-prednisolone acetate-ekhethekileyo ibhekisa kutshintsho olubonakalayo lomhlaba. Ikhonkco yeAntropol. Ngo-2008; 32: 351-353. Jonga i-abstract.
  90. Cho, E., Hankinson, S. E., Rosner, B., Willett, W. C., noColditz, G. A. Ukufundwa okulindelweyo kokutya kwe-lutein / zeaxanthin kunye nomngcipheko wokudodobala okunxulumene nobudala be-macular. NdinguJ. Clin. Ngo-2008; 87: 1837-1843. Jonga i-abstract.
  91. UDherani, M., Murthy, GV, Gupta, SK, Oselula, IS, Maraini, G., Camparini, M., Ixabiso, GM, John, N., Chakravarthy, U., kunye noFletcher, AE Amanqanaba egazi ngevithamini C , Iicarotenoids kunye ne-retinol zinxulunyaniswa ngokuchasene ne-cataract kubemi baseMntla Indian. Tyala imali kwi-Ophthalmol. Ngo-2008; 49: 3328-3335. Jonga i-abstract.
  92. UMoeller, SM, Voland, R., Tinker, L., Blodi, BA, Klein, ML, Gehrs, KM, Johnson, EJ, Snodderly, DM, Wallace, RB, Chappell, RJ, Parekh, N., Ritenbaugh, C ., Kunye neMares, Imanyano ye-JA phakathi kweminyaka yobudala enxulumene nekatala yenyukliya kunye ne-lutein kunye ne-zeaxanthin ekutyeni nakwi-serum kwi-Carotenoids kwi-Study-Related Eye Disease Study, i-Ancillary Study ye-Women's Health Initiative. IArch Ophthalmol. Ngo-2008; 126: 354-364. Jonga i-abstract.
  93. Bartlett, H. E. kunye no-Eperjesi, F.Uvavanyo olulawulwa ngokungahleliwe oluphanda isiphumo se-lutein kunye ne-antioxidant yokutya okunezondlo kwimisebenzi ebonakalayo emehlweni asempilweni. KwiKlinikhi. Ngo-2008; 27: 218-227. Jonga i-abstract.
  94. Adackapara, C. A., Sunness, J. S., Dibernardo, C. W., Melia, B. M., kunye noDagnelie, G. Ukubekwa phambili kwe-cystoid macular edema kunye nozinzo kwi-oct retinal thickness emehlweni ane-retinitis pigmentosa ngexesha lokuvavanywa kwe-lutein yeeveki ezingama-48. Iretina 2008; 28: 103-110. Jonga i-abstract.
  95. Thomson, C.A, Stendell-Hollis, N. R., Rock, C. L., Cussler, E. C., Flatt, S. W., kunye noPierce, J. P. Plasma kunye ne-carotenoids yokutya zinxulunyaniswa noxinzelelo lwe-oxidative kubasetyhini ababekhe banyangwa umhlaza webele. Umhlaza we-Epidemiol. 2007; 16: 2008-2015. Jonga i-abstract.
  96. I-LaRowe, T. L., Mares, J. A., Snodderly, D. M., Klein, M. L., Wooten, B. R., kunye noChappell, R. Macular pigment density kunye ne-maculopathy enxulumene nobudala kwiiCarotenoids kwizifundo ezinxulumene nobudala besifo seLiso. Isifundo esincedisayo sephulo lezempilo labasetyhini. Ophthalmology 2008; 115: 876-883. Jonga i-abstract.
  97. San Giovanni, JP, Chew, EY, Clemons, TE, Ferris, FL, III, Gensler, G., Lindblad, AS, Milton, RC, Seddon, JM, and Sperduto, RDUbudlelwane be-carotenoid yokutya kunye nevithamini A, E , kunye no-C ukungenisa ngokunxulumene nobudala be-macular degeneration kwisifundo sokulawulwa kwetyala: Ingxelo ye-AREDS ye-Nombolo 22. Arch.Ophthalmol. Ngo-2007; 125: 1225-1232. Jonga i-abstract.
  98. URobman, L., Vu, H., Hodge, A., Tikellis, G., Dimitrov, P., McCarty, C., noGuymer, R.Izidlo lutein, zeaxanthin, kunye namafutha kunye nokuqhubela phambili kwe-macular enxulumene nobudala. ukonakala. Ngaba. J. Opthalmol. Ngo-2007; 42: 720-726. Jonga i-abstract.
  99. UTan, J. S., Wang, J., uMkhukula, V., Rochtchina, E., Smith, W., kunye noMitchell, P.Izinto zokulwa ne-antioxidants kunye nexesha elide lokudodobala okunxulumene nobudala be-macular: iBlue Mountains Eye Study. Ophthalmology 2008; 115: 334-341. Jonga i-abstract.
  100. UGouado, I., Schweigert, F. J., Ejoh, R. A., Tchouanguep, M. F., kunye no-Camp, J. V. Amanqanaba enkqubo ye-carotenoids evela kwimango kunye nepapaya edliwe ngeendlela ezintathu (ijusi, isilayidi esitsha nesomileyo). I-Eur. J. Clin, iNutr. Ngo-2007; 61: 1180-1188. Jonga i-abstract.
  101. URicher, S., Devenport, J., kunye noLang, J. C. LAST II: Iimpendulo ezahlukileyo zethutyana ze-macular pigment optical density kwizigulana ezinedrophic ezinxulumene nobudala be-macular degeneration kukutya okune-xanthophylls. Ugqirha wamehlo. Ngo-2007; 78: 213-219. Jonga i-abstract.
  102. Palombo, P., Fabrizi, G., Ruocco, V., Ruocco, E., Fluhr, J., Roberts, R., kunye noMorganti, P.Ukuxhamla kweziphumo zexesha elide zokudityaniswa komlomo / unyango lwe-antioxidant kunye ne-carotenoids I-lutein kunye ne-zeaxanthin kulusu lomntu: isifundo esilawulwa yimfama kabini. Ulusu lwePhemacol. IPhysol 2007; 20: 199-210. Jonga i-abstract.
  103. Cangemi, F. E. TOZAL Study: isifundo esilawulayo solawulo lwe-antioxidant yomlomo kunye ne-omega-3 yokuxhasa i-AMD eyomileyo. I-BMC Ophthalmol 2007; 7: 3. Jonga i-abstract.
  104. Bartlett, H. E. kunye no-Eperjesi, F. Iziphumo ze-lutein kunye ne-antioxidant yokutya okunezondlo ekuchaseni ubuntununtunu kwizifo ezinxulumene nobudala be-macular: ityala elilawulwa ngokungahleliwe. I-Eur. J. Clin, iNutr. Ngo-2007; 61: 1121-1127. Jonga i-abstract.
  105. Hozawa, A., Jacobs, DR, Jr., Steffes, MW, Gross, MD, Steffen, LM, kunye no-Lee, ubudlelwane be-DH bokujikeleza ukugxila kwe-carotenoid ngamanqaku amaninzi okuvuvukala, uxinzelelo lwe-oxidative, kunye ne-endothelial dysfunction: i-Coronary Artery Risk Ukuphuhliswa kwaBantu abaDala abaDala (i-CARDIA) / iNdlela yaBadala yaBantu abaDala kwiiNtsholongwane (YALTA). Iiklinikhi Chem 2007; 53: 447-455. Jonga i-abstract.
  106. URosenthal, JM, Kim, J., de, Monasterio F., Thompson, DJ, Bone, RA, Landrum, JT, de Moura, FF, Khachik, F., Chen, H., Schleicher, RL, Ferris, FL, I-III, kunye ne-Chew, i-EY yokufunda ngokuhambelana nedosi yokuncedisa i-lutein kubantu abaneminyaka engama-60 nangaphezulu. Tyala imali kwi-Ophthalmol. Ngo-2006; 47: 5227-5233. Jonga i-abstract.
  107. I-Trumbo, i-P. Kunye ne-Ellwood, i-K.C Lutein kunye ne-zeaxanthin yokungena kunye nomngcipheko wokudodobala kwe-macular kunye ne-cataract: uvavanyo kusetyenziswa inkqubo yovavanyo olusekwe kubungqina bokutya kunye noLawulo lweziyobisi kumabango ezempilo. NdinguJ. Clin. Ngo-2006; 84: 971-974. Jonga i-abstract.
  108. Schalch, W., Cohn, W., Barker, FM, Kopcke, W., Mellerio, J., Bird, AC, Robson, AG, Fitzke, FF, no van Kuijk, FJ Xanthophyll ukuqokelelwa kwiretina yomntu ngexesha lokudibanisa I-lutein okanye i-zeaxanthin-isifundo se-LUXEA (LUtein Xanthophyll Eye Accumulation). IArch. Ibhayoloji. 2-15-2007; 458: 128-135. Jonga i-abstract.
  109. Moeller, SM, Parekh, N., Tinker, L., Ritenbaugh, C., Blodi, B., Wallace, RB, kunye noMares, JA Imibutho phakathi kwexesha eliphakathi elinxulumene nokwehla kwe-macular kunye ne-lutein kunye ne-zeaxanthin kwi-Carotenoids kwi-Age- Isifundo esimalunga nezifo zamehlo (CAREDS): isifundo esincedisayo sePhulo lezeMpilo laBasetyhini. IArch Ophthalmol. Ngo-2006; 124: 1151-1162. Jonga i-abstract.
  110. UShao, A. noHathcock, J. N. Uvavanyo lomngcipheko we-carotenoids lutein kunye ne-lycopene. Ulawulo lweToxicol Pharmacol 2006; 45: 289-298. Jonga i-abstract.
  111. Umkhukula, V., Rochtchina, E., Wang, J., Mitchell, P., noSmith, W. Lutein kunye ne-zeaxanthin yokutya ukutya kunye nokuwohloka okuhambelana nobudala be-macular. UBr. J. Opthalmol. Ngo-2006; 90: 927-928. Jonga i-abstract.
  112. U-Bahrami, H., Melia, M., no-Dagnelie, G. Lutein supplementation kwi-retinitis pigmentosa: Uvavanyo lwembono esekwe kwi-PC kuvavanyo lwe-placebo olulawulwa kabini olungenamakhonkco [NCT00029289]. I-BMC yeOththalmol. Ngo-2006; 6: 23. Jonga i-abstract.
  113. UHerron, K. L., McGrane, M. M., Waters, D., Lofgren, I. E., Clark, R. M., Ordovas, J. M., noFernandez, M. L. I-ABCG5 polymorphism inegalelo kwimpendulo nganye kwi-cholesterol yokutya kunye ne-carotenoids kumaqanda. J Amanqatha 2006; 136: 1161-1165. Jonga i-abstract.
  114. UAndersen, uLF, uJacobs, u-R., uJr., UGross, uM. D., uSchreiner, uPJ, uDale, uWilliam O., kunye no-Lee, D. H. Imibutho emide phakathi kwesalathiso sobunzima bomzimba kunye ne-serum carotenoids: isifundo seCARDIA. Br J Amanqaku 2006; 95: 358-365. Jonga i-abstract.
  115. UZhao, X., Aldini, G., Johnson, EJ, Rasmussen, H., Kraemer, K., Woolf, H., Musaeus, N., Krinsky, NI, Russell, RM, kunye noYeum, KJ Ukulungiswa kwe-DNA ye-lymphocyte umonakalo ngokuxhaswa kwe-carotenoid kubafazi be-postmenopausal. NdinguJ J Clin 2006; 83: 163-169. Jonga i-abstract.
  116. Coyne, T., Ibiebele, TI, Baade, PD, Dobson, A., McClintock, C., Dunn, S., Leonard, D., kunye noShaw, J. Isifo seswekile kunye ne-serum carotenoids: iziphumo zabantu kufunda eQueensland, e-Australia. NdinguJ J Clin Nutriti 2005; 82: 685-693. Jonga i-abstract.
  117. Ito, Y., Wakai, K., Suzuki, K., Ozasa, K., Watanabe, Y., Seki, N., Ando, ​​M., Nishino, Y., Kondo, T., Ohno, Y., kunye noTamakoshi, A. Ukufa komhlaza wemiphunga kunye nenqanaba le-serum ye-carotenoids, i-retinol, i-tocopherols, kunye ne-folic acid emadodeni nakwabasetyhini: isifundo solawulo lwamatyala esihleli kuFundo lwe-JACC. J Epidemiol. Ngo-2005; 15 iSuppl 2: S140-S149. Jonga i-abstract.
  118. Morganti, P., Fabrizi, G., kunye noBruno, C. Iziphumo zokukhusela ii-antioxidants zomlomo kulusu nakwiliso. Ulusu. Ngo-2004; 3: 310-316. Jonga i-abstract.
  119. Natarajan, L., Rock, CL, Major, JM, Thomson, CA, Caan, BJ, Flatt, SW, Chilton, JA, Hollenbach, KA, Newman, VA, Faerber, S., Ritenbaugh, CK, Gold, E. , Stefanick, ML, Jones, LA, Marshall, JR, kunye noPierce, JP ngokubaluleka kokusebenzisa iindlela ezininzi zovavanyo lokutya. Epidemiology 2004; 15: 738-745. Jonga i-abstract.
  120. UDorgan, JF, Boakye, NA, Uloyiko, TR, Schleicher, RL, Helsel, W., Anderson, C., Robinson, J., Guin, JD, Lessin, S., Ratnasinghe, LD, kunye noTangrea, JA Serum carotenoids kunye ne-alpha-tocopherol kunye nomngcipheko womhlaza wesifo se-nonmelanoma. Umhlaza we-Epidemiol. Ngo-2004; 13: 1276-1282. Jonga i-abstract.
  121. van der Horst-Graat JM, Kok, F.J, kunye no-Schouten, E. G. Plasma carotenoid egxile ngokunxulumene nosulelo olunamandla lokuphefumla kubantu abadala. Br J Amanqaku 2004; 92: 113-118. Jonga i-abstract.
  122. I-Molldrem, K. L., Li, J., Simon, P. W., kunye neTanumihardjo, S. A. Lutein kunye ne-beta-carotene evela kwi-lutein equlathe iminqathe etyheli ayifumaneki ebantwini. NdinguJ. Clin. Ngo-2004; 80: 131-136. Jonga i-abstract.
  123. UDwyer, J.H., Paul-Labrador, M.J, Fan, J., Shircore, A. M., Merz, C.N, kunye noDwyer, K. M.Ukuqhubela phambili kwe-carotid intima-media thickness and plasma antioxidants: Isifundo seLos Angeles Atherosclerosis. IArterioscler iTromb. IVasc. IBiol 2004; 24: 313-319. Jonga i-abstract.
  124. Upritchard, J. E., Schuurman, C. R., Wiersma, A., Tijburg, L. B., Coolen, S. A., Rijken, P. J., kunye noWiseman, S. A. Ukusasazeka okuxhaswe ngeedosi ezilinganiselweyo ze-vitamin E kunye ne-carotenoids kunciphisa i-lipid peroxidation kubantu abadala abasempilweni. NdinguJ J weeKlinikhi ezingama-2003; 78: 985-992. Jonga i-abstract.
  125. Bartlett, H. kunye no-Eperjesi, F. Uvavanyo olulawulwa ngokungahleliwe oluphanda umphumo wokuncedisa okunomsoco ekusebenzeni okubonakalayo kwinto eqhelekileyo, kunye nezifo ezinxulumene nobudala be-macular zichaphazela amehlo: ukuyila kunye nendlela yokusebenza [ISRCTN78467674]. Isondlo. J. 10-10-2003; 2: 12. Jonga i-abstract.
  126. I-Abnet, CC, Qiao, YL, Dawsey, SM, Buckman, DW, Yang, CS, Blot, WJ, Dong, ZW, Taylor, PR, kunye noMark, SD Ukufundwa okulindelekileyo kwe-serum retinol, beta-carotene, beta-cryptoxanthin, kunye ne-lutein / zeaxanthin kunye ne-esophageal kunye ne-gastric cancer. Ulawulo lweZibangela zoMhlaza 2003; 14: 645-655. Jonga i-abstract.
  127. I-Kiokias, S. kunye no-Gordon, M. H. Ukongezwa kokutya kunye nomxube wendalo we-carotenoid kunciphisa uxinzelelo lwe-oxidative. Ikliniki ye-Eur. J. Nutr. Ngo-2003; 57: 1135-1140. Jonga i-abstract.
  128. UWilliam, M. A., Woelk, G. B., King, I. B., Jenkins, L., kunye noMahomed, K. Plasma carotenoids, retinol, tocopherols, kunye lipoproteins kwi-preeclamptic kunye ne-normotensive abafazi abakhulelweyo baseZimbabwe. NdinguJ Hypertens. Ngo-2003; 16: 665-672. Jonga i-abstract.
  129. UGale, C. R., Hall, N. F., Phillips, D. I., kunye noMartyn, C. N. Lutein kunye ne-zeaxanthin kunye nomngcipheko wokuwohloka okuhambelana nobudala be-macular. Tyala imali kwi-Ophthalmol. Ngo-2003; 44: 2461-2465. Jonga i-abstract.
  130. Cardinault, N., Gorrand, J. M., Tyssandier, V., Grolier, P., Rock, E., kunye no-Borel, P. Ukuxhaswa kwexesha elifutshane kunye ne-lutein kuchaphazela i-biomarkers yesimo se-lutein ngokufanayo kwizifundo ezincinci nezindala. Yazisa iGerontol. Ngo-2003; 38: 573-582. Jonga i-abstract.
  131. I-Bone, R. A., Landrum, J. T., Guerra, L.H, kunye neRuiz, C. A. Lutein kunye ne-zeaxanthin izongezo zokutya zonyusa uxinano lwe-macular pigment kunye ne-serum ye-carotenoids ebantwini. UJutut. Ngo-2003; 133: 992-998. Jonga i-abstract.
  132. I-Djuric, Z., Uhley, VE, Naegeli, L., Lababidi, S., Macha, S., kunye noHeilbrun, LK Plasma carotenoids, tocopherols, kunye namandla e-antioxidant kwisifundo se-12 seveki sokungenelela ukunciphisa amafutha kunye / okanye amandla ungeniso. Isondlo 2003; 19: 244-249. Jonga i-abstract.
  133. UFalsini, B., Piccardi, M., Iarossi, G., Fadda, A., Merendino, E., kunye noValentini, P. Impembelelo yokongezwa kwexesha elifutshane le-antioxidant ekusebenzeni kwe-macular kwi-maculopathy enxulumene nobudala: isifundo somqhubi kubandakanya Uvavanyo lwe-electrophysiologic. Ophthalmology 2003; 110: 51-60. Jonga i-abstract.
  134. Olmedilla, B., Granado, F., Blanco, I., kunye noVaquero, M. Lutein, kodwa hayi i-alpha-tocopherol, ukongezwa kuphucula ukusebenza kokubonakalayo kwizigulana ezinekati ejongene nobudala: i-2-y kabini-blind, placebo- isifundo somqhubi esilawulwayo. Isondlo 2003; 19: 21-24. Jonga i-abstract.
  135. I-Berendschot, T., Broekmans, W. M., Klopping-Ketelaars, IA, Kardinaal, A. F., Van, Poppel G., kunye noVan, uNorren D. Ilensi yokuguga ngokunxulumene nokuchazwa kwesondlo kunye nezinto ezinokubangela umngcipheko kwinto enxulumene nobudala bekatsi. IArch Ophthalmol. Ngo-2002; 120: 1732-1737. Jonga i-abstract.
  136. UBowen, P. E., Herbst-Espinosa, S. M., Hussain, E. A., kunye noStacewicz-Sapuntzakis, M. Ukwazisa akuthinteli ukubakho kwe-lutein ebantwini. UJutut. Ngo-2002; 132: 3668-3673. Jonga i-abstract.
  137. IBroekmans, WM, Berendschot, TT, Klopping-Ketelaars, IA, de Vries, AJ, Goldbohm, RA, Tijburg, LB, Kardinaal, AF, kunye nevan van Poppel, G. Macular pigment density on serum and adipose tissue concentrations of lutein kunye ne-serum yoxinzelelo lwe-zeaxanthin. NdinguJ. Clin. 2002; 76: 595-603. Jonga i-abstract.
  138. Snellen, E. L., Verbeek, A. L., Van Den Hoogen, G. W., Cruysberg, J. R., kunye noHoyng, C. B. Neovascular ehambelana nobudala be-macular degeneration kunye nolwalamano lwayo kwi-antioxidant intake. UMthetho weOphthalmol. Ngo-2002; 80: 368-371. Jonga i-abstract.
  139. UValero, M. P., Fletcher, A. E., De Stavola, B. L., Vioque, J., kunye noAlepuz, V. C. I-Vitamin C inxulunyaniswa nomngcipheko wokunciphisa isifo se-cataract kubemi beMeditera. UJutut. Ngo-2002; 132: 1299-1306. Jonga i-abstract.
  140. I-Eichler, O., i-Sies, H., kunye ne-Stahl, W. Amanqanaba afanelekileyo e-lycopene, i-beta-carotene kunye ne-lutein ekhusela ngokuchasene ne-UVB radiation kwi-fibroblastst yabantu. Ifoto yePhotobiol. 2002; 75: 503-506. Jonga i-abstract.
  141. UDuncan, JL, Aleman, TS, Gardner, LM, De Castro, E., Amanqaku, DA, Emmons, JM, Bieber, ML, Steinberg, JD, Bennett, J., Stone, EM, MacDonald, IM, Cideciyan, AV , Maguire, MG, kunye noJacobson, SG Macular pigment kunye ne-lutein supplementation kwi-choroideremia. Ex. Amehlo Res. Ngo-2002; 74: 371-381. Jonga i-abstract.
  142. Iliwa, C. L., Thornquist, M. D., Neuhouser, M. L., Kristal, A. R., Neumark-Sztainer, D., Cooper, D. A., Patterson, R. E., kunye noCheskin, L. J. Ukutya kunye nendlela yokuphila enxulumene ne-lutein egazini nakwizidlo. UJutut. Ngo-2002; 132: 525S-530S. Jonga i-abstract.
  143. UTaylor, A., Jacques, PF, Chylack, LT, Jr., Hankinson, SE, Khu, PM, Rogers, G., Friend, J., Tung, W., Wolfe, JK, Padhye, N., kunye noWillett. , WC Ukuthatha ixesha elide iivithamini kunye neecarotenoids kunye nokungahambi kakuhle kwecortical kunye ne-posterior subcapsular lens opacities. NdinguJ. Clin. Ngo-2002; 75: 540-549. Jonga i-abstract.
  144. I-Curran-Celentano, J., Hammond, BR, Jr., Ciulla, TA, Cooper, DA, Pratt, LM, kunye neDanis, RB Unxibelelwano phakathi kokutya okutyayo, ukugxila kwe-serum, kunye ne-retinal ye-lutein kunye ne-zeaxanthin kubantu abadala kwi-Midwest Inani labemi. NdinguJ. Clin. 2001; 74: 796-802. Jonga i-abstract.
  145. Gale, C. R., Hall, N. F., Phillips, D. I., kunye noMartyn, C. N. Plasma iivithamini ze-antioxidant kunye ne-carotenoids kunye ne-cataract enxulumene nobudala. Ophthalmology 2001; 108: 1992-1998. Jonga i-abstract.
  146. UJacques, PF, Chylack, LT, Jr., Hankinson, SE, Khu, PM, Rogers, G., Friend, J., Tung, W., Wolfe, JK, Padhye, N., Willett, WC, kunye noTaylor, A. Ukutya ixesha elide kwezondlo kunye ne-opacities yeelensi zenyukliya ezineminyaka yobudala. IArch Ophthalmol. 2001; 119: 1009-1019. Jonga i-abstract.
  147. IJunghans, A., Sies, H., kunye ne-Stahl, W. Macular pigment lutein kunye ne-zeaxanthin njengesihluzi sokukhanya esiluhlaza esifundwe kwi-liposomes. IArch. Ibhayoloji. 7-15-2001; 391: 160-164. Jonga i-abstract.
  148. I-Aleman, TS, Duncan, JL, Bieber, ML, De Castro, E., Marks, DA, Gardner, LM, Steinberg, JD, Cideciyan, AV, Maguire, MG, noJacobson, SG Macular pigment kunye ne-lutein supplementation kwi-retinitis pigmentosa kunye ne-Usher syndrome. Tyala imali kwi-Ophthalmol. 2001; 42: 1873-1881. Jonga i-abstract.
  149. UDwyer, JH, Navab, M., Dwyer, KM, Hassan, K., Ilanga, P., Shircore, A., Hama-Levy, S., Hough, G., Wang, X., Drake, T., IMerz, i-CN, kunye neFogelman, i-AM Oxygenated carotenoid lutein kunye nokuqhubela phambili kwe-atherosclerosis yasekuqaleni: isifundo seLos Angeles atherosclerosis. Ukujikeleza kwe-6-19-2001; 103: 2922-2927. Jonga i-abstract.
  150. O'Neill, ME, Carroll, Y., Corridan, B., Olmedilla, B., Granado, F., Blanco, I., van den, Berg H., Hininger, I., Rousell, AM, Chopra, M ., Southon, S., kunye noThurnham, DI Idatha yaseYurophu ye-carotenoid yokuvavanya ukungena kwe-carotenoid kunye nokusetyenziswa kwayo kuphononongo lokuthelekiswa kwamazwe amahlanu. Br J Amanqaku 2001; 85: 499-507. Jonga i-abstract.
  151. Olmedilla, B., Granado, F., Southon, S., Wright, AJ, Blanco, I., Gil-Martinez, E., Berg, H., Corridan, B., Roussel, AM, Chopra, M., kunye no-A. kunye noThurnham, i-DI Serum egxile kwi-carotenoids kunye neevithamini A, E, kunye no-C kwizifundo zolawulo ezivela kumazwe amahlanu aseYurophu. Br J Amanqaku 2001; 85: 227-238. Jonga i-abstract.
  152. Mares-Perlman, JA, Fisher, AI, Klein, R., Palta, M., Block, G., Millen, AE, kunye noWright, JD Lutein kunye ne-zeaxanthin ekutyeni nakwi-serum kunye nokunxibelelana kwabo ne-maculopathy enxulumene nobudala. kuvavanyo lwesithathu lwezempilo kuzwelonke kunye novavanyo lwesondlo. Ndingu. J. Epidemiol. 3-1-2001; 153: 424-432. Jonga i-abstract.
  153. UBeatty, S., Murray, I. J., Henson, D. B., uCarden, D., Koh, H., noBoulton, M. E. Macular pigment kunye nomngcipheko wokuwohloka okuhambelana nobudala kwizifundo ezivela kubemi baseMantla Yurophu. Tyala imali kwi-Ophthalmol. 2001; 42: 439-446. Jonga i-abstract.
  154. I-Bone, R. A., Landrum, J. T., Mayne, S. T., Gomez, C. M., Tibor, S. E., kunye ne-Twaroska, E. E. I-pigment ye-Macular emehlweni abo banikelayo nangaphandle kwe-AMD: isifundo solawulo lwamatyala. Tyala imali kwi-Ophthalmol. 2001; 42: 235-240. Jonga i-abstract.
  155. Chopra, M., O'Neill, M. E., Keogh, N., Wortley, G., Southon, S., noThurnham, D. I. Impembelelo yokunyuka kweziqhamo kunye nokutya kwemifuno kwiplasma kunye neepoprotein carotenoids kunye ne-LDL oxidation kubantu abatshayayo nabangatshayiyo. KwiKlinikhi. Ngo-2000; 46: 1818-1829. Jonga i-abstract.
  156. Berendschot, T., Goldbohm, R. A., Klopping, W. A., van de, Kraats J., van Norel, J., kunye no-van Norren, D. Impembelelo yokongezwa kwe-lutein kwi-macular pigment, kuvavanywa ngeendlela ezimbini zeenjongo. Tyala imali kwi-Ophthalmol. Ngo-2000; 41: 3322-3326. Jonga i-abstract.
  157. I-Bone, R. A., Landrum, J., Dixon, Z., Chen, Y., kunye neLlerena, C. M. Lutein kunye ne-zeaxanthin emehlweni, i-serum kunye nokutya kwezifundo zabantu. Ex. Amehlo Res. Ngo-2000; 71: 239-245. Jonga i-abstract.
  158. Rapp, L. M., Maple, S. S., kunye no-Choi, J. H. Lutein kunye ne-zeaxanthin yokugxininisa kwiimbumba zangaphandle zeentonga ezivela kwi-retina kunye ne-peripheral retina yabantu. Tyala imali kwi-Ophthalmol. Ngo-2000; 41: 1200-1209. Jonga i-abstract.
  159. ISumantran, V. N., Zhang, R., Lee, D. S., kunye noWicha, M. S. Ukwahlula okwahlukileyo kwe-apoptosis kwinto yesiqhelo xa ithelekiswa ne-mammary epithelium ye-lutein kunye ne-retinoic acid. Umhlaza we-Epidemiol. Ngo-2000; 9: 257-263. Jonga i-abstract.
  160. het Hof, K. H., Tijburg, L. B., Pietrzik, K., kunye neWeststrate, J. A. Impembelelo yokondla imifuno eyahlukeneyo kumanqanaba e-plasma ye-carotenoids, i-folate kunye ne-vitamin C. Iziphumo zokuphazamiseka kwematriki yemifuno. Br. J Nutriti 1999; 82: 203-212. Jonga i-abstract.
  161. I-Siems, W. G., Sommerburg, O., kunye ne-van Kuijk, F. J.Lycopene kunye ne-beta-carotene zibola ngokukhawuleza kune-lutein kunye ne-zeaxanthin xa ichanabeka kwi-pro-oxidants ezahlukeneyo kwi-vitro. Ii-Biofactors 1999; 10 (2-3): 105-113. Jonga i-abstract.
  162. UWright, A. J., Hughes, D. A., Bailey, A.L, kunye noSouthon, S. Beta-carotene kunye ne-lycopene, kodwa hayi i-lutein, ukongezwa kuyatshintsha iprofayili ye-asidi yeplasma ye-acid yabantu abangatshayiyo abasempilweni. J kwiKlinikhi yaseMed 1999; 134: 592-598. Jonga i-abstract.
  163. UCastenmiller, J. J., Lauridsen, S. T., Dragsted, L. O., het Hof, K. H., Linssen, J. P., kunye neNtshona, uC. E. beta-carotene ayitshintshi amanqaku e-enzymatic and nonenzymatic antioxidantJ Nutriti 1999; 129: 2162-2169. Jonga i-abstract.
  164. ISommerburg, O. G., Siems, W. G., Hurst, J. S., Lewis, J. W., Kliger, D. S., kunye no-van Kuijk, F. J. Lutein kunye ne-zeaxanthin banxulunyaniswa ne-photoreceptors kwi-retina yomntu. Ikhonkco. Ngo-1999; 19: 491-495. Jonga i-abstract.
  165. Paetau, I., Rao, D., Wiley, E. R., Brown, E. D., kunye noClevidence, B. A. Carotenoids kwiiseli zomntu ze-buccal mucosa emva kwe-4 wk yokongezwa ngejusi yetumato okanye izongezo ze-lycopene. NdinguJ J Clin Nutr 1999; 70: 490-494. Jonga i-abstract.
  166. I-Richer, S. ARMD -ulingo (uchungechunge lwamatyala) idatha yokungenelela kwendalo. J Ndingu-Optom. Assoc 1999; 70: 24-36. Jonga i-abstract.
  167. I-Handelman, G. J., Nightingale, Z. D., Lichtenstein, A. H., Schaefer, E. J., kunye neBlumberg, J. B. Lutein kunye ne-zeaxanthin egxile kwi-plasma emva kokongezwa kokutya kunye ne-yolk yeqanda. NdinguJ. Clin. Ngo-1999; 70: 247-251. Jonga i-abstract.
  168. UGarcia-Closas, R., Agudo, A., Gonzalez, C. A., kunye noRiboli, E.Ukungeniswa kwee-carotenoids ezithile kunye ne-flavonoids kunye nomngcipheko womhlaza wemiphunga kwabasetyhini e-Barcelona, ​​eSpain. Umhlaza weNutriti 1998; 32: 154-158. Jonga i-abstract.
  169. Li, L., Chen, CY, Aldini, G., Johnson, EJ, Rasmussen, H., Yoshida, Y., Niki, E., Blumberg, JB, Russell, RM, kunye noYeum, uKJ Ukongezwa kunye ne-lutein okanye i-lutein kunye nezicatshulwa zeti eluhlaza azitshintshi uxinzelelo lwe-oxidative kubantu abadala abonele ngokwaneleyo. J Isondlo. Ngo-2010; 21: 544-549. Jonga i-abstract.
  170. Isono, H. P., Liu, D., kunye neLam, D. S. Ukulungiswa kwendlela yokuphila, ukutya okunesondlo kunye neevithamini zokongeza ukwanda okuhambelana nobudala be-macular. U-Acta Ophthalmol. Ngo-2013; 91: 6-11. Jonga i-abstract.
  171. UJohnson, E. J., McDonald, K., Caldarella, S. M., Chung, H. Y., Troen, A. M., kunye no Snodderly, D. M. Iziphumo zokuqonda zolingo lokuhlola i-docosahexaenoic acid kunye ne-lutein supplementation kubafazi abadala. Isondlo Neurosci 2008; 11: 75-83. Jonga i-abstract.
  172. Johnson, E. J., Chung, H. Y., Caldarella, S. M., kunye no Snodderly, D. M. Impembelelo ye-lutein eyongezelelweyo kunye ne-docosahexaenoic acid kwi-serum, lipoproteins, kunye ne-macular pigmentation. NdinguJ J Clin Nutr 2008; 87: 1521-1529. Jonga i-abstract.
  173. Ito, Y., Wakai, K., Suzuki, K., Tamakoshi, A., Seki, N., Ando, ​​M., Nishino, Y., Kondo, T., Watanabe, Y., Ozasa, K., kunye no-Ohno, Y. I-Serum carotenoids kunye nokusweleka kumhlaza wemiphunga: isifundo solawulo lwamatyala esidlekweni sophando lwaseJapan lweCohort (JACC). Umhlaza weSci. Ngo-2003; 94: 57-63. Jonga i-abstract.
  174. I-Kawabata, F. kunye neTsuji, T.Iziphumo zokongezwa kokutya ngokudityaniswa kweoyile yeentlanzi, ukukhutshwa kwebilberry, kunye ne-lutein kwiimpawu ezizimeleyo ze-asthenopia ebantwini. I-Biomed Res 2011; 32: 387-393. Jonga i-abstract.
  175. U-Eliassen, AH, Hendrickson, SJ, Brinton, LA, Buring, JE, Campos, H., Dai, Q., Dorgan, JF, Franke, AA, Gao, YT, Goodman, MT, Hallmans, G., Helzlsouer, KJ , Hoffman-Bolton, J., Hulten, K., Sesso, HD, Sowell, AL, Tamimi, RM, Toniolo, P., Wilkens, LR, Winkvist, A., Zeleniuch-Jacquotte, A., Zheng, W. (1). , kunye noHankinson, SE Ukujikeleza i-carotenoids kunye nomngcipheko womhlaza wamabele: Uhlalutyo oluhlanganisiweyo lwezifundo ezisibhozo ezinokubakho. J Natl. Umhlaza Inst. 12-19-2012; 104: 1905-1916. Jonga i-abstract.
  176. I-Aune, D., Chan, DS, Vieira, AR, Navarro Rosenblatt, DA, Vieira, R., Greenwood, DC, kunye neNorat, T.Izidlo xa kuthelekiswa nokuxinana kwegazi kwe-carotenoids kunye nomngcipheko womhlaza wamabele: uphononongo olucwangcisiweyo kunye nemeta- Uhlalutyo lwezifundo ezinokwenzeka. NdinguJ J Clin Nutriti 2012; 96: 356-373. Jonga i-abstract.
  177. Hu, F., Wang, Yi B., Zhang, W., Liang, J., Lin, C., Li, D., Wang, F., Pang, D., kunye noZhao, Y. ICarotenoids kunye nomhlaza webele. Umngcipheko: Uhlalutyo lweemeta kunye neemeta-regression. Umhlaza webele Res. Unyango. Ngo-2012; 131: 239-253. Jonga i-abstract.
  178. Chong, E. W., Wong, T. Y., Kreis, A. J., Simpson, J. A., noGuymer, R.H.Izinto zokulwa ne-antioxidants kunye nothintelo lokuqala lokuwohloka okuhambelana nobudala be-macular: uphononongo lwenkqubo kunye nohlalutyo lweemeta. BMJ 10-13-2007; 335: 755. Jonga i-abstract.
  179. ICardinault, N., Tyssandier, V., Grolier, P., Winklhofer-Roob, BM, Ribalta, J., Bouteloup-Demange, C., Rock, E., kunye no-Borel, P. Ukuthelekiswa kweempendulo ze-postprandial chylomicron carotenoid kwizifundo ezincinci nezindala. I-Eur. J. iNutr. Ngo-2003; 42: 315-323. Jonga i-abstract.
  180. Heinrich, U., Gartner, C., Wiebusch, M., Eichler, O., Sies, H., Tronnier, H., kunye noStahl, W.Ukuxhaswa nge-beta-carotene okanye inani elifanayo le-carotenoids ekhuselekileyo ikhusela abantu I-erythema ebangelwe yi-UV. J Utyando 2003; 133: 98-101. Jonga i-abstract.
  181. Malila, N., Virtamo, J., Virtanen, M., Pietinen, P., Albanes, D., kunye noTeppo, L.Izidlo kunye ne-serum alpha-tocopherol, beta-carotene kunye ne-retinol, kunye nomngcipheko wesifo somhlaza kumadoda. abatshayayo. I-Eur. J. Clin, iNutr. Ngo-2002; 56: 615-621. Jonga i-abstract.
  182. IHininger, IA, Meyer-Wenger, A., Moser, U., Wright, A., Southon, S., Thurnham, D., Chopra, M., van den, Berg H., Olmedilla, B., Favier, I-AE, kunye neRoussel, AM Akukho ziphumo zibalulekileyo ze-lutein, i-lycopene okanye i-beta-carotene yokuncedisa kwiimpawu zebhayoloji zoxinzelelo lwe-oxidative kunye ne-LDL oxidizability kwizifundo zabantu abadala ezisempilweni. J Ndingu-Coll Nutrut 2001; 20: 232-238. Jonga i-abstract.
  183. Yamini, S., West, KP, Jr., Wu, L., Dreyfuss, ML, Yang, DX, kunye noKhatry, SK Amanqanaba ajikelezayo e-retinol, tocopherol kunye ne-carotenoid eNepali abasetyhini abakhulelweyo nabasemva kokubeleka abalandela i-beta-carotene yexesha elide kunye ne-vitamin A yokuncedisa. I-Eur. J. Clin, iNutr. 2001; 55: 252-259. Jonga i-abstract.
  184. van den Berg H. Iziphumo ze-lutein kukufakwa kwe-beta-carotene kunye nokuqaqamba. I-Int J Vitam Nutr Res 1998; 68: 360-5. Jonga i-abstract.
  185. IAlbanes D, uVirtamo J, Taylor PR, et al. Iziphumo zokuncedisa i-beta-carotene, ukutshaya icuba, kunye nokusela utywala kwi-serum carotenoids kwi-Alpha-Tocopherol, Beta-Carotene Cancer Study Prevention. NdinguJ J Clin Nutr 1997; 66: 366-72. Jonga i-abstract.
  186. UReboul E, uThap S, uPerrot E, et al. Iziphumo ze-antioxidants eziphambili zokutya (i-carotenoids, i-gamma-tocopherol, i-polyphenols, kunye ne-vitamin C) kwi-alpha-tocopherol yokufakwa. I-Eur J yeklinikhi yeNutrr 2007; 61: 1167-73. Jonga i-abstract.
  187. IBloomer RJ, uFry A, uSchilling B, uChiu L, et al. Ukuxhaswa kwe-Astaxanthin akukuthinteli ukwenzakala kwemisipha kulandela ukuzivocavoca umzimba kumadoda aqeqeshwe kukuxhathisa. I-Int J yezeMidlalo yokuSebenza ngeZondlo 2005; 15: 401-12. Jonga i-abstract.
  188. UParisisi V, uTedeschi M, uGallinaro G, et al. IiCarotenoids kunye ne-antioxidants ezinxulumene nobudala be-maculopathy yokufunda e-Italiya: Uhlengahlengiso lwe-multifocal electroretinogram emva konyaka omnye. Ophthalmology 2008; 115: 324-33. Jonga i-abstract.
  189. UThurmann PA, uSchalch W, uAebischer JC, et al. IPlasma kinetics ye-lutein, zeaxanthin, kunye ne-3-dehydro-lutein emva kwedosi ezininzi zomlomo zesongezelelo se-lutein. NdinguJ J Clin Nutriti 2005; 82: 88-97. Jonga i-abstract.
  190. U-Lee EH, uFaulhaber D, uHanson KM, et al. Ukutya i-lutein kunciphisa i-radiation ye-radiation ebangelwa kukudumba kunye nokucinezelwa komzimba. J Tyala iDermatol 2004; 122: 510-7. Jonga i-abstract.
  191. IGruber M, uChappell R, uMillen A, et al. I-Correlates ye-serum lutein + zeaxanthin: iziphumo ezivela kuPhando lweSizwe lwezeMpilo kunye noVavanyo lwezeMpilo. J Amanqatha 2004; 134: 2387-94. Jonga i-abstract.
  192. I-Bowen PE, i-Herbst-Espinosa SM, i-Hussain EA, i-Stacewicz-Sapuntzakis M. I-Esterification ayithinteli ukubakho kwe-lutein ebantwini. J Amanqatha 2002; 132: 3668-73. Jonga i-abstract.
  193. UKoh HH, uMurray IJ, uNolan D, et al. Iiplasma kunye neempendulo ze-macular kwisongezo se-lutein kwizifundo ezingena-maculopathy ezinxulumene nobudala: isifundo somqhubi. Ukucaciswa kwamehlo Res 2004; 79: 21-27. Jonga i-abstract.
  194. UChung HY, uRasmussen HM, uJohnson EJ. I-Lutein bioavailability iphezulu ukusuka kumaqanda atyetyiswe nge-lutein kunakwizincedisi kunye nesipinatshi emadodeni. J Amanqatha 2004; 134: 1887-93. Jonga i-abstract.
  195. IShuphupp C, u-Olano-Martin E, uGerth C, et al. I-Lutein, zeaxanthin, i-macular pigment, kunye nomsebenzi wokubonwayo kwizigulana zabantu abadala be-cystic fibrosis. NdinguJ J Clin Nutriti 2004; 79 1045-52. Jonga i-abstract.
  196. van Leeuwen R, Boekhoorn S, Vingerling JR, et al. Ukutya ukutya kwee-antioxidants kunye nomngcipheko wokudodobala macular. IJAMA 2005; 294: 3101-7. Jonga i-abstract.
  197. I-Knekt P, uRitz J, uPereira MA, et al. Iivithamini ze-antioxidant kunye nomngcipheko wesifo sentliziyo: uhlalutyo oluhlanganisiweyo lwamaqela angama-9. NdinguJ J Clin Nutriti 2004; 80: 1508-20. Jonga i-abstract.
  198. UOlmedilla B, uGranado F, uSouthon S, et al. I-multicentre yaseYurophu, indawo elawulwa yi-placebo elawulwa yi-alpha-tocopherol, ioyile yesundu ene-carotene, i-lutein okanye i-lycopene: uhlalutyo lweempendulo ze-serum. Iiklinikhi zeSci (Lond) 2002; 102: 447-56. Jonga i-abstract.
  199. Ukhetho E, uSeddon JM, uRosner B, et al. Ukufundelwa kokutya iziqhamo, imifuno, iivithamini, kunye ne-carotenoids kunye nomngcipheko we-maculopathy enxulumene nobudala. IArch Ophthalmol 2004; 122: 883-92. Jonga i-abstract.
  200. UMontonen J, uKnkt P, uJarvinen R, uReunanen A.Ukutya ukutya okune-antioxidant kunye nomngcipheko wohlobo lweswekile 2. Unonophelo lweSwekile 2004; 27: 362-6. Jonga i-abstract.
  201. UGoodman GE, uSchaffer S, u-Omenn GS, kunye no-al. Umanyano phakathi komngcipheko womhlaza wemiphunga kunye neprostate, kunye ne-serum micronutrients: iziphumo kunye nezifundo ezifundwe kwi-beta-carotene kunye ne-retinol yesilingo sokusebenza. Umhlaza we-Epidemiol Biomarkers Prev 2003; 12: 518-26. Jonga i-abstract.
  202. Isityebi S, Stiles W, Statkute ​​L, et al. Imaski ephindwe kabini, elawulwa yi-placebo, yolingo olungenamkhethe lwe-lutein kunye ne-antioxidant yokuncedisa kungenelelo lwe-atrophic enxulumene nobudala be-macular degermation: isifundo seVeterans LAST (Isilingo seLutein Antioxidant Supplement Trial). I-Optometry 2004; 75: 216-30. Jonga i-abstract.
  203. UHammond BR Jr, uJohnson EJ, uRussell RM, et al. Ukuguqulwa kokutya koxinzelelo lwe-macular pigment yabantu. Tyala imali kwi-Ophthalmol Vis Sci 1997; 38: 1795-801 .. Jonga i-abstract.
  204. Isifundo seLiso lokuLawulwa kwezifo zeSifo seLiso. Ubume be-antioxidant kunye ne-neovascular age-related degeneration. IArch Ophthalmol 1993; 111: 104-9 .. Jonga i-abstract.
  205. UDagnelie G, uZorge IS, uMcDonald TM. I-Lutein iphucula ukusebenza kokubonakalayo kwezinye izigulana ezinokonakala kwe-retinal: isifundo somqhubi nge-Intanethi. I-Optometry 2000; 71: 147-64 .. Jonga i-abstract.
  206. UJohnson EJ, uHammond BR, uYeum KJ, et al. Ubudlelwane phakathi kwe-serum kunye ne-tishu egxile kwi-lutein kunye ne-zeaxanthin kunye ne-macular pigment density. NdinguJ J Clin Nutriti 2000; 71: 1555-62 .. Jonga i-abstract.
  207. Yeum KJ, Ahn SH, Rupp de Paiva SA, okqhubekayo. Ukulungelelaniswa phakathi kokugxilwa kwe-carotenoid kwi-serum kunye nezihlunu eziqhelekileyo zesifuba se-adipose yabasetyhini abanesifo esibuhlungu sesifuba okanye umhlaza webele. J Nutriti 1998; 128: 1920-6 .. Jonga i-abstract.
  208. UKim MK, Ahn SH, uLee-Kim. Ubudlelwane be-serum alpha-tocopherol, i-carotenoids kunye ne-retinol ngomngcipheko womhlaza wamabele. Ukutya okunesondlo 2001; 21: 797-809.
  209. Umkhukula V, uSmith W, uWang JJ, et al. Ukutya ukutya okuchaseneyo ne-antioxidant kunye neziganeko zemaculopathy ezinxulumene nokufikisa: i-Blue Mountains Eye Study. I-Ophthalmology 2002; 109: 2272-8 .. Jonga i-abstract.
  210. USchunemann HJ, uGrant BJ, uFreudenheim JL, et al. Ubudlelwane benqanaba le-serum ye-antioxidant iivithamini C kunye no-E, i-retinol kunye ne-carotenoids ezinomsebenzi we-pulmonary kuluntu ngokubanzi. NdinguJ J wokuKhathalela uKhathalelo ngeMed 2001; 163: 1246-55 .. Jonga abstract.
  211. IVandenLangenberg GM, Mares-Perlman JA, Klein R, okqhubekayo. Unxibelelwano phakathi kokungena kwi-antioxidant kunye ne-zinc kunye neminyaka emi-5 yezehlo ezinxulumene nobudala besifo seBeverver Dam. NdinguJ Epidemiol 1998; 148: 204-14. Jonga i-abstract.
  212. IRoodenburg AJ, Leenen R, van het Hof KH, et al. Inani lamafutha ekudleni lichaphazela ukungafumaneki kwe-lutein esters kodwa hayi nge-alpha-carotene, beta-carotene, kunye nevithamini E ebantwini. NdinguJ J Clin 2000; 71: 1187-93. Jonga i-abstract.
  213. UMores-Perlman JA, uBrady WE, uKlein R, et al. Iserum antioxidants kunye nokudodobala okunxulumene nobudala be-macular kwisifundo esisekwe kulawulo lwamatyala. IArch Ophthalmol 1995; 113: 518-23. Jonga i-abstract.
  214. IGossage C, iDeyhim M, iMoser-Veillon PB, et al. Iziphumo zokongezwa kwe-beta-carotene kunye nokwanyisa kwi-carotenoid metabolism kunye nokwanda kwe-mitogenic T-lymphocyte. NdinguJ J Clin 2000; 71: 950-5. Jonga i-abstract.
  215. USeddon JM, uAjani UA, uSperduto R, et al. I-carotenoids yokutya, iivithamini A, C, kunye no-E, kunye nokudodobala okuhambelana nobudala obuhambelana nobudala. IJAMA 1994; 272: 1413-20. Jonga i-abstract.
  216. UMores-Perlman JA, uBrady WE, uKlein BE, et al. I-Serum carotenoids kunye ne-tocopherols kunye nobukhali benyukliya kunye ne-cortical opacities. Tyala imali kwi-Ophthalmol Vis Sci 1995; 36: 276-88. Jonga i-abstract.
  217. Isilayidi ML, uPotter JD, uCoates A, et al. Ukutya kwezityalo kunye nomhlaza wekolon: uvavanyo lokutya okuthile kunye nezondlo ezinxulumene nazo (eUnited States). Ulawulo lweZibangela zoMhlaza 1997; 8: 575-90. Jonga i-abstract.
  218. I-Steinmetz KA, uMbumbi JD. Imifuno, iziqhamo, kunye nomhlaza. I. Izifo zengqondo. Umhlaza oBanga uLawulo 1991; 2: 325-57. Jonga i-abstract.
  219. Isilayidi ML, uBenson J, uCurtin K, et al. IiCarotenoids kunye nomhlaza wekolon. NdinguJ J Clin 2000; 71: 575-82. Jonga i-abstract.
  220. IHammond BR Jr, iWooten BR, iSnodderly DM, et al. Ukuxinana kwelensi yekristali yomntu inxulumene ne-macular pigment carotenoids, lutein kunye ne-zeaxanthin. I-Optom Vis Sci 1997; 74: 499-504. Jonga i-abstract.
  221. ISommerburg O, Keunen JE, intaka AC, van Kuijk FJ. Iziqhamo kunye nemifuno eyimithombo ye-lutein kunye ne-zeaxanthin: i-pigment macular emehlweni abantu. UBr J Ophthalmol 1998; 82: 907-10. Jonga i-abstract.
  222. UTeikari JM, uVirtamo J, uRautalahti M, et al. Ukuxhaswa kwexesha elide kunye ne-alpha-tocopherol kunye ne-beta-carotene kunye ne-cataract ehambelana nobudala. UMthetho weOphthalmol Scand 1997; 75: 634-40. Jonga i-abstract.
  223. UTeikari JM, uRautalahti M, Haukka J, et al. Isiganeko sokusebenza kwecataract kubantu baseFinland abatshayayo abangachaphazelekiyo yi-alpha tocopherol okanye izongezo ze-beta carotene. J Epidemiol yoLuntu yezeMpilo 1998; 52: 468-72. Jonga i-abstract.
  224. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Ukuthatha i-Antioxidant kunye nomngcipheko weziganeko ezinxulumene nobudala benyukliya kwiSifundo seLiso leDama laseBeverver. NdinguJ Epidemiol 1999; 149: 801-9. Jonga i-abstract.
  225. UChasan-Taber L, uWillett WC, uSeddon JM, et al. Ukuchaneka Isifundo esinokubakho sokufakwa kwe-carotenoid kunye ne-vitamin A kunye nomngcipheko wokukhutshwa kwe-cataract kubafazi base-US. NdinguJ J Clin Nutriti 1999; 70: 509-16. Jonga i-abstract.
  226. UBrown L, uRimm EB, uSeddon JM, et al. Isifundo esinokwenzeka sokutya kwe-carotenoid kunye nomngcipheko wokukhutshwa kwe-cataract kumadoda ase-US. NdinguJ J Clin Nutr 1999; 70: 517-24. Jonga i-abstract.
  227. Lyle BJ, Mares-Perlman JA, Klein BE, et al. Ukuthatha i-Antioxidant kunye nomngcipheko weziganeko ezinxulumene nobudala benyukliya kwi-Beaver Dam Eye Study. NdinguJ Epidemiol 1999; 149: 801-9. Jonga i-abstract.
  228. UHankinson SE, uStampfer MJ, uSeddon JM, et al. Ukutya okunesondlo kunye nokukhutshwa kwe-cataract kubafazi: isifundo esinokwenzeka. BMJ 1992; 305: 335-9. Jonga i-abstract.
  229. ISeddon JM, Ajani UA, Sperduto RD, et al. I-carotenoids yokutya, iivithamini A, C, kunye no-E, kunye nokudodobala okuhambelana nobudala obuhambelana nobudala. Isifundo seLiso lokuLawulwa kwezifo zeSifo seLiso. IJAMA 1994; 272: 1413-20. Jonga i-abstract.
  230. I-Koonsvitsky BP, i-Berry DA, okqhubekayo. I-Olestra ichaphazela ukugxila kwe-serum ye-alpha-tocopherol kunye ne-carotenoids kodwa hayi ivithamin D okanye imeko ye-vitamin K kwizifundo zokuphila simahla. J Amanqatha 1997; 127: 1636S-45S. Jonga i-abstract.
  231. I-Kostic D, i-White WS kunye ne-Olson JA. Ukufakwa emathunjini, ukucoca i-serum, kunye nokunxibelelana phakathi kwe-lutein kunye ne-beta-carotene xa kulawulwa kubantu abadala ngokwahlukeneyo okanye ngokudibeneyo. NdinguJ J Clin Nutriti 1995; 62: 604-10. Jonga i-abstract.
  232. van den Berg H, van Vliet T.Iziphumo zexeshana, iidosi zomlomo ezizodwa ze-beta-carotene kunye ne-lutein okanye i-lycopene kwi-beta-carotene kunye neempendulo ze-retinyl ester kwiqhekeza elityebileyo le-lipoprotein eline-triacylglycerol. NdinguJ J Clin Nutr 1998; 68: 82-9. Jonga i-abstract.
  233. Umhlaba we-Landrum JT, uBone RA, uJoa H, et al. Isifundo sonyaka omnye se-macular pigment: isiphumo seentsuku ezili-140 zesongezelelo se-lutein. Ukucaciswa kwamehlo Res 1997; 65: 57-62. Jonga i-abstract.
  234. I-DM enobunzima. Ubungqina bokhuselo ngokuchasene nokudodobala kwe-macular ngokwe-carotenoids kunye neevithamini ze-antioxidant. NdinguJ J Clin Nutriti 1995; 62: 1448S-61S .. Jonga i-abstract.
  235. Spraycar M, ed. Isichazi-magama sikaStedman's Medical. Ngomhla wama-26. IBaltimore, MD: UWilliams kunye noWilkins, ngo-1995.
  236. Pratt S. Uthintelo lokutya lokudodobala okunxulumene nobudala be-macular. J Ndingu-Optom Assoc 1999; 70: 39-47. Jonga i-abstract.
  237. UBerson EL, uRosner B, uSandberg MA, et al. Uvavanyo olungenamsebenzi lwevithamini A kunye novithamin E wokuncedisa i-retinitis pigmentosa. IArch Ophthalmol 1993; 111: 761-72. Jonga i-abstract.
  238. I-CD yeNaylor, O'Rourke K, iDetsky AS, uBaker JP. Isondlo somzali nge-branched-chain amino acids kwi-hepatic encephalopathy. Uhlalutyo lweemeta. I-Gastroenterology 1989; 97: 1033-42. Jonga i-abstract.
  239. UMajumdar SK, uShaw GK, uThomson AD, et al. Utshintsho kwiipateni zeplasma zeamino acid kwizigulana ezinesifo esinganyangekiyo ngexesha lokurhoxa kwe-ethanol: iimpembelelo zazo zeklinikhi. Iingcamango ze-1983; 12: 239-51. Jonga i-abstract.
  240. UVorgerd M, uGrehl T, uJager M, et al. Ukuxhamla Yenza unyango kwi-myophosphorylase defence (isifo seMcArdle): ityala elilawulwa yi-placebo. IArch Neurol 2000; 57: 956-63. Jonga i-abstract.
  241. Foster S, uTyler VE. I-Herbal ethembekileyo yeTyler: Isikhokelo esiSebenzisayo sokuSebenzisa iiHerbs kunye neZonyango ezinxulumene noko. I-3rd ed., IBinghamton, NY: I-Haworth Herbal Press, ngo-1993.
  242. INewall CA, uAnderson LA, uPhilpson JD. Unyango ngamayeza esintu: Isikhokelo saBasebenzi bezeMpilo. ILondon, e-UK: Icandelo leendaba lonyango, ngo-1996.
  243. UTyler VE. IiHerbs zoKhetho. I-Binghamton, NY: Imveliso yezeMveliso yezeMveliso, ngo-1994.
  244. Blumenthal M, ed. IKhomishini epheleleyo yaseJamani i-E Monographs: Isikhokelo sonyango kumaYeza eHerbal. Dlulisa. S. Klein. IBoston, MA: IBhunga laseMelika leBhotani, i-1998.
  245. Monographs ekusebenziseni amayeza iziyobisi zezityalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.
Ukuhlaziywa okokugqibela-02/23/2021

Kucetyiswa

IPemphigus vulgaris
Iyeza

IPemphigus vulgaris

I-Pemphigu vulgari (PV) kukuphazami eka okuzenzekelayo kolu u. Ibandakanya ukudumba kunye nezilonda (ukhukuli eko) lolu u kunye neembumba.Amajoni omzimba aveli a izilwa-buhlungu ngokucha ene neeproten...
Ukutya emva kokubopha esiswini
Iyeza

Ukutya emva kokubopha esiswini

Ubune-laparo copic banding banding. Olu tyando lwenze ukuba i i u akho ibe incinci ngokuvala indawo ye i u akho ngebhanti ehlengahlengi wayo. Emva kotyando uzakutya ukutya okuncinci, kwaye ngekhe ukwa...